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Abstract 
INTRODUCTION: The first beats of the developing heart resemble peristaltic 
contractions with electrical activity arising in the precursor to the sino-atrial 
node and propagating through the heart tube. The purpose of this thesis was to 
investigate channelrhodopsin-2 (ChR-2) based optogenetic stimulation of induced 
pluripotent stem cell derived cardiomyocytes (iPSC-CMs) with the intention of 
using the technique to investigate the functional effects of directional activation 
on immature cardiomyocytes. 
METHODS: Commercially supplied iPSC-CMs (Axiogenesis) were made to express 
ChR-2 (H134R) via an adeno-associated viral vector (AAV1.CAG.hChR2(H134R)-
mCherry.WPRE.SV40). Cell function was assessed before and after pacing using 
in house software to measure contraction kinetics and strength-duration curves 
to determine cell excitability. α-actinin staining allowed for analysis of 
sarcomere length, inhomogeneity and alignment. 
RESULTS: Commercially supplied iPSC-CMs had significantly shorter sarcomeres 
than their adult counterparts (1.766 ± 0.017 µm vs 2.028 ± 0.079 µm 
respectively, P=0.0125 unpaired t-test). A viral load of 2500GC/cell produced 
ChR-2 expression sufficient for optical control of these cells 5 days post 
transfection. The chronaxie of photostimulated cells (1.53 ± 0.32 ms) did not 
differ significantly from that of electrically stimulated cells (2.17 ± 0.44 ms, 
P=0.2434 unpaired t-test). Prolonged photostimulation of a single site led to a 
loss of stimulation:contraction coupling after 2.22 ± 1.26 hours and almost 
complete loss of contractile function after 24 hours. Alternating stimulation 
between multiple sites allowed cells to be paced for 96 hours and allowed 
directional electrical activation to be imposed on immature heart cells. 96 hours 
of directional pacing produced no changes in cell structure or cell excitability 
but produced a significant reduction in contraction upstroke time (72.03 ms vs 
48.85 ms P=0.023 one-way ANOVA) 24 hours after the termination of stimulation.  
CONCLUSIONS: This project has demonstrated that replicating the directional 
electrical activity of the developing heart can induce a modest change in 
contractile function that may represent a step towards functional maturation of 
commercially available iPSC-CMs.
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1.1 Introduction 
During a myocardial infarction regions of ischaemia of variable size are formed 
which can result in the loss of many millions of cardiomyocytes1 making up a 
significant percentage of the total myocardium. Loss of these cells causes 
increased strain on the remaining myocardium as it attempts to maintain cardiac 
output. The increased strain causes pathological remodelling which can lead to 
decreased cardiac output and heart failure. To progress to heart failure, an 
infarct in the left ventricle must kill approximately 25% of the 4 billion cells 
contained within1, indicating that both the site and the size of the infarct are 
important in determining patient outcome. In 2010 heart failure was attributed 
to 279,000 deaths in the US2 with 33% of heart failure patients having had a 
previous MI3, indicating that current strategies for preventing MI progression to 
HF are ineffective. More recently many groups have begun developing methods 
of generating cardiomyocytes from pluripotent cells to replace those lost during 
MI. These cells can then be combined with a collagen matrix or grown in a 
monolayer to produce cardiac tissue grafts suitable for transplantation into the 
damaged heart to improve cardiac function.  
The ability to produce cardiomyocytes from pluripotent stem cells is of great 
interest to another aspect of cardiac medicine: Toxicity screening. 
Approximately 33% of all drugs are withdrawn during human clinical trials due to 
cardiotoxic effects not seen during animal studies4. The primary reason that 
cardiotoxic effects are not observed in animal models is electrophysiological 
variation between species. Cardiomyocytes derived from human pluripotent 
stem cells therefore allows drugs to be screened on human cardiac tissue and is 
thought to yield clinically relevant toxicity data, with the caveat that current 
products yield cardiac cells at an embryonic stage of development 
1.2 Embryonic development 
At Day 15 of human uterine development, progenitor cells from the primitive 
streak migrate superiorly to form a bilateral plate known as the heart field 
(Figure 1.1). At this point the progenitor cells are divided into distinct 
populations of endodermal cells and mesodermal cells. The mesodermal cells are 
further separated into the haematopoietic and cardiac lineage. Unbalanced 
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increases in any of these populations can lead to heart defects5,6. Segregation of 
these cell lineages is determined by wingless-related integration site protein 
(Wnt) and bone morphogenetic protein (BMP) signalling which is modulated by a 
gradient of Activin/Nodal signalling present throughout the developing heart. 
The heart field is split spatiotemporally into the first and second heart fields. At 
20 days of development, cells from the first heart field migrate medially where 
they differentiate in response to endodermal BMP signalling to form the 
primitive heart tube7 (Figure 1.1). At this stage, cells of the secondary heart 
field are held in a progenitor state via canonical Wnt signalling. At day 21 cells 
from the secondary heart field migrate to the heart tube which acts as a scaffold 
allowing the secondary cells to differentiate and lead to the generation of 
structures such as the left and right atria as well as the outflow tracts 
comprising the conotruncus. The sinus venosus is also formed at this stage from 
a pool of progenitors originating in the inferolateral border of the secondary 
heart field8. This process is complete at day 22 when the heart tube first begins 
the beat in a peristaltic manner9 (Figure 1.1). While the first few beats of the 
heart may be due to spontaneous activity of the cardiomyocytes10 it has been 
shown that, at this stage, the heart is likely under the control of a primordial 
sinoatrial node (SAN) present in the sinus venosus11. At this stage action 
potential conduction is homogenous throughout the heart tube resulting in a 
sinusoidal ECG12. 
Around day 28 rightward looping of the heart tube occurs (Figure 1.1). At this 
stage cells migrate to the outflow tract from the cardiac neural crest to form 
the aortic arch and the aortic arch arteries. Septation of the ventricles and atria 
then begins due to the influence of GATA-4, TBX-5 and NKX2.513-15. Formation of 
the Atrioventricular valve (AVV) also begins at this stage due to BMP2 and TBX2 
interactions16,17. Around the same time, the true SAN first develops18 from the 
cells of the sinus venosus. The formation of the AVV, which has a slower 
conduction velocity than atrial and ventricular cells, means that the previously 
peristaltic contraction of the heart is separated into serial contractions of the 
atria and ventricles. This is reflected in a more matured ECG phenotype12. At 
this stage, well developed sodium, calcium and potassium currents have been 
detected and L-type calcium current appears to be the dominant excitatory 
current19. 
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Septation continues until the four distinct chambers of the heart are formed 
around day 50 (Figure 1.1). Throughout this time the phenotypes of atrial and 
ventricular cells diverge due to modulation of heart and neural crest derivatives 
expressed 2 (Hand2) and Delta-like protein 1 signalling by microRNAs mir1-1 and 
mir1-2 in the ventricles and atria respectively20. At this stage, sodium current 
has increased in density to become the dominant excitatory current with rapidly 
activating potassium currents, such as Ito, being the dominant repolarising 
currents. It is important to note that there are no chamber specific differences 
in expression of excitatory currents, however there are significant chamber 
differences in repolarising currents19. 
1.2.1 EC coupling during cardiac development 
In the mature heart calcium entry via the L-Type Ca2+ channels causes Ca2+ 
release from the sarcoplasmic reticulum via the ryanodine receptor(RyR2)21. In 
the foetal cardiomyocyte the SR is known to exist, due to the presence of 
caffeine-induced SR Ca2+ release22, however it is reported to be underdeveloped 
based on results from electron microscopy23 and isolation of SR vesicles24,25. 
These results are consistent with evidence that ryanodine has little effect on 
cellular contraction23. 
These results imply that the Ca2+ transient in the foetal heart is comprised 
mainly of Ca2+ entering the cell via sarcolemmal Ca2+ channels. This is reinforced 
by evidence that foetal calcium transients are blocked by the L-type Ca2+ 
channel blocker nifedipine22. The density of the L-type Ca2+ current has been 
shown to increase throughout foetal development19,26 and continues to increase 
after birth. This is in contrast to the outward Na+/Ca2+ exchange (NCX) current 
density which increases throughout foetal development peaking around birth 
before decreasing during postnatal dvelopment27-29. This postnatal decrease 
accompanies an increase in maturation of the SR24,25 indicating that NCX may 
compensate for the immature SR during foetal development but plays a lesser 
role in the mature heart. There is evidence to suggest that this change in 
dominance may be due to hormonal signalling from the thyroid30. 
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Figure 1.1 Embryonic cardiac development 
Diagrammatic representation of human foetal cardiac development. LV: left ventricle. RA: Right 
Atria. LA: Left Atria. SV: Sinus venosus. CT: Conotruncus. RV: Right Ventricle. SAN: Sinoatrial 
Node. AVV/AVN: Atrioventricular valve/node. Ao: Aorta. PA: Pulmonary artery. RSCA: Right 
subclavian artery. RCA: right carotid artery. LCA: Left carotid artery. LSCA: Left subclavian artery. 
SVC: Superior Vena cava. IVC: Inferior vena cava. 
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Ca2+ sparks, discrete Ca2+ release events caused by activation of a single cluster 
of RyR2 channels, are virtually absent in the foetal heart22. Sparks can be 
categorised as spontaneous (independent of L-type Ca2+) or evoked (triggered by 
calcium entry via L-type Ca2+ channel31). It has been shown that sparks begin to 
develop in the neonatal heart arising initially in close proximity to the surface 
membrane and appearing throughout the whole cell over time22. This is likely 
due to the increase in colocalisation of RyR2 and L-type Ca2+ channels that 
accompanies development of the t-tubules22. Given that spontaneous Ca2+ sparks 
arise largely as a result of high SR Ca2+, and neonatal cardiomyocytes have a 
significantly reduced SR capacity32, it is unsurprising that evoked sparks are 
prevalent in neonatal cardiomyocytes. 
1.3 Post-natal development 
It is important to note that throughout foetal development, the Carnegie stages 
allow for a simple interspecies comparison of developmental landmarks, i.e. 
studies on rat or mouse development can be easily translated into human 
development33. The absence of such a system for post-natal development makes 
interspecies comparisons much more difficult.  
In the days following birth, growth of the heart changes from hyperplasic growth 
to hypertrophic growth. Increases in cell volume and binucleation shows that 
this change in dominance occurs around day 4 in the rat with approximately 90% 
of cardiomyocytes becoming binucleated by day 1234. By day 18 in rat the T-
tubular system is almost completely developed22 and by day 20, L-type Ca2+ 
current is not significantly different from adult cells. However at this point the 
Ca2+ content of the sarcoplasmic reticulum is still significantly lower than that of 
an adult cell32. In new born humans (< 2 weeks of age) cells display a 
characteristic flat or slightly negative force-frequency relationship. In infants (3–
14 months), this has changed to a positive force frequency relationship akin to 
the adult heart29. In the adult heart, additional calcium release from 
intracellular stores is thought to arise due to activation of the inositol 1,4,5-
triphosphate (IP3) receptor by IP3 generated by G protein-coupled receptors in 
the surface membrane35. This IP3 signalling pathway has been detected in 
neonatal rat cardiomyocytes as young as 1 day old36,37. 
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It is difficult to determine at which time point cardiomyocytes become adult. 
There is no adequate marker of maturity in these cells, several different 
characteristics of the cells are similar to adult at different time points and there 
is no clear consensus as to what characteristics must be present before a cell 
may be classed as adult. For example, although T-tubules are almost fully 
developed at day 18 their presence is not suitable as a marker of maturity as 
they develop as a response to increased cell size (Figure 1.2). 
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Figure 1.2 Relation of t-tubule density to cell size 
T-tubule density increases with increasing cell size. Coloured bands show the cell width of neonatal 
(blue), post-natal (red) and adult (green) rat ventricular cardiomyocytes. Figure adapted from 
Richards et al38 
1.4 Pluripotent stem cell derived cardiomyocytes 
Traditionally the main source of pluripotent cells were embryonic stem cells. 
Use of these cells has large ethical concerns due to the destruction of human 
embryos. More recently retroviral transfection of fibroblasts with transcription 
factors (Oct3/4, Sox2, Klf4, and c-Myc) 39,40 generated pluripotent cells which 
were similar to embryonic stem cells in terms of surface morphology, gene 
expression, and surface proteins.  
Both embryonic (ESC) and induced (iPSC) pluripotent stem cells have been used 
to generate cardiomyocytes using various means. 
1.5 Current strategies for cardiomyocyte development 
A number of groups have attempted to produce cardiac differentiation of stem 
cells by replicating conditions found during uterine development. In addition to 
work on pluripotent cells, a great deal of work has been carried out on neonatal 
rat ventricular myocytes (NRVM) as they have a similar level of maturity as 
derived cardiomyocytes.  
1.5.1 Biochemical 
A logical step in deriving cardiomyocytes from stem cells is to mimic the 
signalling pathways that arise during physiological development. Treatment of 
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embryonic stem cells with BMP4 and Activin A can cause cardiogenesis in both 
ESCs and iPSCs which can be enhanced by the addition of inhibitors of 
Activin/nodal signalling41. Inhibition of canonical Wnt signalling (responsible for 
maintaining a progenitor state during development) has been shown be a potent 
inducer of cardiomyocytes42. These methods produce cardiomyocytes at a 
prenatal or neonatal maturity level. In order to produce more adult like cells, 
the next logical step is to mimic peri- and post-natal factors. 
One such factor is the thyroid hormone triiodothyronine (T3) which has been 
shown to cause cardiomyocyte maturation. Foetal sheep cardiomyocytes 
demonstrated increased cell width, binucleation and increased expression of 
SERCA in response to increased levels of T3 during in vivo development43. T3 has 
also been shown to increase expression of Nkx2.5, SERCA and RyR2 in murine 
ESC-CM’s. In addition to an increased amplitude of caffeine induced Ca2+ 
transients (representing a more mature SR) these cells also had a more negative 
resting membrane potential again indicating increased maturity44. Improved Ca2+ 
handling and increased SERCA expression with a concomitant increase in 
contractile force were also shown in human iPSC-CMs following 1 week exposure 
to T345. 
A common factor throughout the foetal, post-natal and adult heart is the 
presence of micro RNA’s specifically miR-146. This microRNA was shown to 
decrease the resting potential and APD of ESC-CMs via an increase in repolarising 
potassium currents and a decrease in the pacemaker current. Given the regional 
differences in expression of miR-1 isoforms during development20, It is possible 
that stem cell derived cardiomyocytes with chamber specific phenotypes may be 
produced.  
1.5.2 Electrical stimulation 
From day 22 onwards the foetal heart is electrically active. It has been shown 
that electrical stimulation can cause cardiogenesis in ESCs through the 
generation of intracellular ROS47. Further to this it has been shown that pacing 
of NRVM at physiological rates produced increases in fractional shortening, cell 
alignment and cell coupling48 as well as increased: NCX expression; action 
potential duration; and conduction velocity49. 
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Pacing of human ESC-CMs has demonstrated similar increases in action potential 
duration as well as increased SERCA expression and increased caffeine induced 
Ca2+ release50. A recent study has shown that chronic pacing (10 days) of human 
iPSC engineered heart tissue increases fractional shortening and contractile 
force as well as producing a more mature structural phenotype in terms of cell 
shape and size51.  
1.5.3 Mechanical 
During physiological development, the 3D structure of the heart and the 
rhythmic contractions mean that developing cardiomyocytes experience 
significant mechanical loading. Significant amounts of work have gone into 
investigating the effects these conditions on cardiomyocyte maturation. 
One method that has been successful in maturing both NRVM and ESC-CMs is 
cyclic stretching. Sustained cyclic stretching has been shown to cause 
characteristic morphological and electrophysiological changes associated with 
maturation in NRVM52,53. 10% strain at 2 Hz for 2 weeks increased expression of 
cardiac specific markers such as α-MHC, GATA-4 and Nkx2.5 in ePSCs54. Cycle 
stretching of ESC-CMs has also been shown to cause significant increases in cell 
size, sarcomere organisation55 as well as increased electrical coupling, increased 
Ca2+ re-uptake, and increased expression of the inward rectifying potassium 
channel and voltage gated sodium channel56. 
Other attempts at replicating developmental conditions have been carried out 
through the use of cell patterning and 3D culture. This has led to a great amount 
of research into hydrogels of different compositions that have differing electrical 
and mechanical properties, many of which have been shown to increase 
cardiomyocyte differentiation. Micropatterning of cells onto various substrates 
can be used to control cell orientation and cause increases in myofilament 
alignment, electrical coupling57, and force of contraction58. 3D culture methods 
utilising hydrogel embedded with rigid support columns have been shown to 
cause cardiac progenitor cells from mouse ESCs and human iPSCs to differentiate 
into cardiomyocytes in a highly functional engineered heart tissue59,60. 
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1.5.4 Combined strategies 
Recently, focus has shifted to the development of maturation methods that 
encompass several aspects of physiological maturation.  
One research group developed a novel bioreactor using both mechanical and 
electrical stimulation within the same system to mimic isovolumic contraction. 
NRVMs were cultured in a fibrin construct wrapped around inflatable latex 
tubing such that, when air was injected and removed from the tubing, the 
construct was stretched circumferentially. Cyclic stretching to 5% strain at 1Hz 
followed by a delayed electrical stimulus (mimicking isovolumic contraction 
during adult cardiac cycle) produced a distinct increase in SERCA expression that 
was not produced by isolated mechanical or electrical stimulation61.  
Another study investigated the effects of electrical stimulation (ES) in the 
presence of IGF-1 on the maturation of NRVM within a polyglycerol scaffold. 
They showed visually that there was greater expression of connexin 43 (Cx43) 
under dual stimulation when compared to ES or IGF-1 alone. They also showed a 
marked increase in contractility of the engineered tissue following dual 
stimulation compared to little or no increase with individual stimuli62.  
1.6 Cardiomyocyte maturity 
Currently available stem cell derived cardiomyocytes have a broad range of 
maturation levels ranging from the equivalent of day 22 embryonic 
cardiomyocytes to neonatal cardiomyocytes. Compared to their adult 
counterparts derived cardiomyocytes differ in a number of ways. 
1.6.1 Structure 
Stem cell derived cardiomyocytes tend to be circular in appearance63,64 and have 
a much smaller surface area than fully mature cells65,66. In addition to the small 
size there is a significantly lower, but variable level of organisational alignment 
of sarcomeric proteins α-actinin and β-MHC50,63,67. Concomitant with the smaller 
surface area is infrequent or absent transverse tubules (T-Tubules) 68,69. Absence 
of a mature T-tubule network may contribute to the immature nature of calcium 
handling within these cells. 
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1.6.2 Contractile function and ECC 
In the mature cell, calcium induced calcium release from the sarcoplasmic 
reticulum is the major source of intracellular calcium during EC coupling21. Stem 
cell derived cardiomyocytes have lower expression of many calcium handling 
proteins such as RyR2 and phospholamban70 and have mixed responsiveness to 
calcium releasing drugs such as caffeine and thapsigargin71-74. As a result, the 
calcium transients of these cells are smaller as well as being poorly coupled to 
electrical activation due to the absence of T-tubules68. This, combined with the 
poor sarcomeric organisation means that the contractile force of derived 
cardiomyocytes is significantly lower (nN/mm2)75 than adult cells (µN/mm2)76. An 
important alternative Ca2+ handling pathway in adult cardiomyocytes, IP3 
mediated Ca2+ release and store operated calcium entry (SOCE), have both been 
shown to be present in derived cardiomyocytes77-79. 
1.6.3 Electrophysiological properties 
A major distinguishing feature of derived cardiomyocytes is the spontaneous 
activity they demonstrate45,50,64. The presence of the pacemaker current (If) and 
lack of inward rectifier current (Ik1)80 causes the resting membrane potential to 
increase gradually towards the threshold for voltage gated sodium channels (INa) 
resulting in spontaneous activation. It has been suggested that stem cell derived 
cardiomyocytes exhibit differential atrial or nodal phenotypes at different stages 
of development with appropriate levels of both If and Ik180. The reduced 
spontaneous activity of the cells exhibiting the atrial phenotype correlates well 
with studies showing reduced numbers of spontaneously active cells when cells 
are plated at lower densities81 indicating that spontaneous activity in monolayers 
may be due to the presence of nodal cells.  
The reduced Ik1 expression in derived cardiomyocytes leads to a more positive 
membrane potential than mature cells64,82. This more positive membrane 
potential, coupled with decreased expression of sodium channels83, can cause a 
decreased upstroke velocity82,84. Expression of connexin 43 has been shown to be 
dispersed throughout the membrane of derived cardiomyocytes contrasting the 
highly polarised distribution found in adult myocytes. This combined with the 
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decreased upstroke velocity results in a conduction velocity that is significantly 
lower than adult heart tissue85,86. 
1.7 Applications 
1.7.1 Transplantation 
An obvious use of stem cell derived cardiomyocytes is to replace the cells lost 
during MI to prevent progression to heart failure. Indeed, studies have shown 
minor improvements in cardiac function following successful transplantation of 
cardiomyocytes in animal models of heart failure87-89. These cells are an ideal 
candidate for transplantation as they can be patient specific, thereby removing 
any complications due to rejection. Despite this, the clinical use of stem cell 
derived cardiomyocytes for this purpose is currently infeasible for several 
reasons.  
Firstly, the poor electrical coupling, calcium handling and spontaneous activity 
of the derived cells means that the transplanted cells are pro-arrhythmic in 
nature89 although this is contested by research showing suppression of post-MI 
arrhythmias90.  
Secondly, the low survival rates88 means that a large number of cells are needed 
to replace those lost during MI91. In addition to this rejection free grafting is only 
possible via iPSC-CMs derived from somatic cells of the individual patients. The 
high cost and low efficacy of the techniques42 used in the generation of these 
cells means that currently, generation of sufficient patient specific cells would 
be prohibitively time consuming and expensive. 
1.7.2 Cardiotoxicity assays and drug discovery 
Around 33% of all drugs are withdrawn during clinical trials due to unforeseen 
cardiotoxic effects4. This is due to electrophysiological differences between the 
animal models used and the clinical target (humans). A more clinically relevant 
substrate for pharmacological testing would allow for increased drug safety as 
well as increases in drug discovery. Stem cell derived cardiomyocytes have been 
shown to have similar current densities to isolated human cells92-96 indicating 
that they may have a greater clinical relevance than animal models.  
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The validity of these cells as a drug screening candidate is supported by studies 
showing arrhythmia generation in response to drugs that are known to be pro-
arrhythmic97. Another advantage of the cell-based drug assay is the use of the 96 
well format, allowing for high throughput screening of multiple drugs.  
Once a reliably mature cell line is available independent assays may be used to 
investigate the effects of drugs in both healthy and diseased hearts. One caveat 
to the use of cell-based assay systems is that many drugs have cardiotoxic 
effects due to long term exposure or have toxic products produced by drug 
metabolism. Given the limited lifetime of these cells in culture and the lack of a 
complex drug metabolism, these toxic effects would not be observable in a cell-
based system.  
An alternative to a purely cell-based system is the “Organ on a chip” design. 
Advances in microfluidics has allowed for the creation of new in vitro models 
that more accurately replicate the complex, multicellular 3D structure of 
several organs including lung98, liver99, kidneys100, and heart101. The eventual 
goal of these artificial organs is to create a “Human on a chip” where the 
separate organs are connected. This system would allow drug metabolism to be 
mimicked more accurately and be could be used to replace animal models. 
1.8 Optogenetics 
Under resting conditions, electrically excitable cells demonstrate a 
transmembrane potential difference caused by a build-up of positive and 
negative charges along the cell membrane. (Figure 1.3A) The resting membrane 
potential is negative relative to the outside due to the ionic composition of the 
intracellular and extracellular fluids. An action potential is triggered when the 
membrane potential becomes increasingly positive and reaches a threshold value 
for the opening of voltage sensitive ion channels. In cardiac physiology, the 
increase in membrane potential arises from the pacemaker current found in cells 
within the sino-atrial node. The membrane potential can be artificially made 
more positive using electric field stimulation. Negative charge from the cathode 
displaces positive charge from the external membrane causing an increased 
external negative charge. This in turn repels negative charge from the internal 
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side of the membrane causing the membrane potential to become more positive 
and activating voltage-gated ion channels (Figure 1.3B). 
 
Figure 1.3 Optogenetic stimulation vs field stimulation 
A) Representative diagram of charge distribution in an excitable cell at rest (resting membrane 
potential). B) Field stimulation displaces positive charge from the outside of the outside of the cell 
membrane leading to a more positive membrane potential. C) Current injection through a cation 
channel (optically activated or otherwise) causes positive charge to accumulate on the inner 
membrane around the channel leading to a more positive membrane potential. 
The effectiveness of field stimulation is heavily dependent on the material the 
electrode is comprised of; the distance between the cell and the electrode; and 
the composition of any surrounding tissue102. Alongside these variables there are 
several disadvantages associated with field stimulation. Long periods of 
stimulation, and even short repetitive bursts of stimulation can cause 
electrolysis of the extracellular solution leading to changes in pH and the 
production of free radicals, both of which can cause cell damage. Field 
stimulation is also confounded by a lack of selectivity. All cells within the 
electric field undergo stimulation meaning it is impossible to achieve patterned 
stimulation.  
These limitations can be avoided through the use optogenetic stimulation. 
Optogenetics is the use of light activated proteins to control or monitor the 
behaviour of excitable cells103. In the majority of studies, this translates to the 
addition of light-sensitive ion channels, however optogenetics also covers the 
use of fluorescent sensor proteins that respond to changes in cell membrane 
potential or calcium concentration104-106. There are a large variety of light 
activated ion channels, most of which are depolarising whilst a few others are 
hyperpolarising107. 
One of the most widely used ion channels is chanelrhodopsin-2 (ChR-2)108-110. 
Channelrhodopsin-2 is a 7 transmembrane α helix protein108 which when 
illuminated with 400-500 nm111 light produces a photocurrent characterised by 
an initial peak followed by a reduced but sustained steady state current until 
cessation of illumination108. The photocurrent is caused by isomerisation of the 
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all-trans-retinal complex to C13-cis-retinal111 causing a conformational change 
within the pore region of the protein. This in turn allows cations to enter the 
cell causing depolarisation108,109(Figure 1.3C). 
As only cells that express the protein are stimulated, optogenetics has proven 
useful for neuroscience as specific cell types can be targeted meaning that the 
exact anatomical structure does not need to be known103,112. In addition to this, 
the multitude of different optogenetic channels means that cells can be both 
stimulated or inhibited which can allow for behavioural modulation113-115. 
The field of cardiac electrophysiology has also seen an increase in the use of 
optogenetic proteins because of the number of advantages it has over traditional 
field electrodes. The increased spatiotemporal resolution of optogenetic 
stimulation allows specific sub-regions of the myocardium to be selectively 
stimulated, creating stimulation patterns that can disrupt re-entrant arrhythmias 
with minimal risk of secondary pro-arrhythmic effects116,117. As there is no need 
for an electric shock, pain and damage caused by implantable automatic 
defibrillators118-120 could potentially be avoided using optogenetic defibrillators. 
An important consideration when comparing field stimulation to optogenetic 
stimulation is how the magnitude of the change in transmembrane potential (ΔV) 
relates to increasing stimulus strength and how this relationship is altered by 
changes in resting membrane potential. Field stimulation causes a surface 
potential gradient which, as the cell interior is isopotential, causes a spatially 
varying transmembrane potential difference throughout the cell, leading to ion 
channel activation and depolarisation121. ΔV increases with increasing field 
strength, and is largely unaffected by membrane potential122. Optogenetic 
stimulation, by comparison, causes a ΔV by injection of a photocurrent. ChR-2 
photocurrent, and therefore ΔV, increases non-linearly with light intensity123, 
with saturation reflecting activation of all available channels124. ChR-2 also 
shows strong inward rectification109 meaning that, unlike field stimulation, ChR-2 
ΔV is heavily dependent on membrane potential. 
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1.8.1 Optogenetic maturation of iPSC-CMs 
It was hypothesised that, through careful patterning of optogenetic stimulation, 
the directional electrical activity observed at day 22 within the developing heart 
(Figure 1.1) could be replicated within a monolayer of iPSC-CMs. By mimicking 
embryonic electrophysiological conditions, the maturity of commercially 
available iPSC-CMs could be improved. 
1.9 Aims of project 
The aim of this project was to investigate the use of optogenetic stimulation, via 
ChR-2, as a means of altering cardiomyocyte phenotype. More specifically the 
project aimed to: 
1) Determine optimal virus load for effective ChR-2 transfection in iPSC-CMs 
2) Assess equivalence of optogenetic and field stimulation in iPSC-CMs. 
3) Trial long term photostimulation protocols on iPSC-CMs and test the effect 
on structural and functional phenotype. 
4) Determine the effect of directional electrical activation on structural and 
functional phenotype. 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 2: General Methods 
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2.1 Solutions 
For plating and maintenance of iPSC-CM’s, Cor4U media was used. For fixing and 
imaging cells phosphate buffered saline was used. 
2.1.1 Cor4U media 
Cor4U cell plating and maintenance media was provided by Axiogenesis. For 
plating, media was supplemented with 3 µM puromycin to prevent fibroblast 
growth. For chronic pacing experiments, media was supplemented with 1% 
penicillin and streptomycin. 
2.1.2 Phosphate Buffered Saline (PBS) 
2.67 KCl, 1.47 KH2PO4, 138 NaCl and 8 Na2HPO4-7H2O (concentrations in mM). 
1% bovine serum albumin (BSA) (by mass) was added for use in 
immunohistochemistry. 
2.2 Methods 
2.2.1 Cell plating and viral transfection 
Glass bottomed culture dishes were coated with 1:100 fibronectin (Sigma 
Aldrich):PBS (with Ca2+ and Mg2+). The plates were then left at 37°C for 3 hours 
before the fibronectin was removed. A cryovial containing 1 million Cor4U 
cardiomyocytes (Axiogenesis, Germany) was removed from liquid nitrogen 
storage and 500 µl of prewarmed Cor4u media was then added before the 
cryovial was warmed in a water bath at 37°C until the pellet of cells detached. 
The cells and media were then removed from the cryovial and added slowly to a 
50ml falcon tube containing 3ml prewarmed media. The cryovial was then 
washed with a further 1ml of media which was then added to the falcon tube 
resulting in a final volume of 5ml. 10 µl of the cell suspension was added to 10 µl 
trypan blue before being added to a haemocytometer for counting. After 
counting the media volume was altered such that the cell concentration was 
250,000 cells/ml for seeding in inserts or 125,000 cells/ml for seeding in 96 well 
plates. Cells were then seeded at a density of 25,000 cells per well and then 
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kept in an incubator overnight. The media was replaced as early as possible the 
following day to remove any remaining cryopreservatives.  
It was at this point that channelrhodopsin-2 was introduced into the cells via an 
adeno associated virus (AAV1.CAG.hChR2(H134R)-mCherry.WPRE.SV40). The 
1.17×1013GC/ml stock was split into 2 µl aliquots to prevent repeat freeze-thaw 
cycles. For transfection, a 2 µl aliquot was added to 1ml cell media resulting in a 
solution of 2.34×1010 GC/ml. The appropriate volume for the selected 
multiplicity of infection (MOI) was then added to each well to be transfected. 
For example, an MOI of 2,500 at a cell density of 25,000 would require 6.25×107 
genome copies (GC) meaning 2.67 µl of the diluted viral solution was added to 
each well. The cells were left in the presence of virus for 24 hours, at which 
time the viral solution was removed, and fresh media added. Media was 
subsequently replaced every 48 hours. The media containing viral particles and 
any plastic or glassware used in transfection was treated with bleach overnight 
before disposal as a safety precaution. 
2.2.2 Optical stimulation  
A 470 nm LED (Cairn research) was used to optically stimulate cells via an 
Olympus IX71 Microscope with a 40x objective. The minimum optical power of 
the LED was reduced using a 10% neutral density (ND) filter (Comar). Pulsed 
illumination was possible by controlling the power level of the LED using an 
external Digitimer DS2A stimulator coupled to a Digitimer DG2A train generator 
(Figure 2.1). Using this setup, the minimum optical power required to pace cells 
with 1:1 coupling was recorded.  
2.2.3 Strength duration curves 
Starting with a 20 ms pulse width, photostimulation intensity was increased until 
1:1 coupling occurred. The pulse width was then reduced and the 
photostimulation intensity increased to the new threshold. This was repeated 
until the threshold intensity exceeded the maximum output of the LED. 
Rheobasic current (the threshold power at an “infinite” pulse width) and the 
chronaxie (the pulse width at which the threshold is twice the rheobasic power) 
were taken from the resulting plot of power vs pulse-width. 
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Figure 2.1 Photostimulation optical pathway 
Optical pathway diagram of microscope setup used for photostimulation. A 470 nm LED was 
powered by a Cairn research opto-LED power supply. A Digitimer DS2A stimulator coupled to a 
Digitimer DG2A train generator was used to control the optical power level. 
2.2.4 Contractility recordings 
Contracting cells were recorded at 100 frames per second for 8-10 seconds using 
a Hamamatsu orca flash 4.0 camera in conjunction with HCI imaging software. 
Brightfield illumination was used throughout recording and the level was 
unchanged between recordings to prevent changing levels of background ChR-2 
activation. To conserve disk space and reduce memory usage a 600x600 pixel 
sub-array was used instead of the full sensor area. The resulting image sequence 
was then analysed using an algorithm developed by Dr Francis Burton which has 
since been further developed into an automated, open source software tool 
(MUSCLEMOTION)125. Absolute changes in pixel intensity between a reference 
frame and the frame of interest allow for contraction to be assessed. For every 
pixel within the frame of interest, the equivalent pixel in the reference frame is 
subtracted and the difference is presented in absolute numbers. Unchanged 
pixels result in low values, while changed pixels result in higher values. The 
mean pixel intensity of the resulting image gives a quantifiable measure of pixel 
displacement. 
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 When all frames within an image sequence are compared to a common 
reference frame (imgi -imgref = imgresult) the output describes the total 
displacement over time. If the reference frame is dependent upon the frame of 
interest (imgref = imgi-1) the output describes the relative interframe 
displacement defined as contraction velocity. An exert from Sala et al describes 
several improvements made to the algorithm:125 
“MUSCLEMOTION has been modified to handle typical experimental recordings 
by (i) improving the signal-to-noise ratio (SNR), (ii) automating reference 
frame selection and (iii) programming built-in checks to validate the 
generated output data. The SNR was increased by isolating the pixels of 
interest in a three-step process: i) maximum projection of pixel intensity in 
the complete contraction stack, ii) creation of a binary image of this 
maximum projection with a threshold level equal to the mean grey value plus 
standard deviation and iii) multiplication of the pixel values in this image by 
the original contraction and speed of the contraction image stack. This 
process allowed the algorithm to work on a region of interest with movement 
above the noise level only” (Figure 2.2 Schematic overview of 
MUSCLEMOTION). 
 
Figure 2.2 Schematic overview of MUSCLEMOTION 
Green blocks indicate basic steps of the algorithm. Dark green blocks indicate important user input 
choices. Plots within light green blocks indicate results. Optional steps are shown in blue blocks, 
with graphical representation of the analysed parameters indicated by red lines. Three result files 
are generated containing the raw data: “contraction.txt”, “speed-of-contraction.txt” and “overview-
results.txt”. Furthermore, three images showing relevant traces and a log file are generated and 
saved (not shown in schematic). Figure adapted from Sala et al125  
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Figure 2.3 Example of contractility analysis 
A) i) Brightfield reference image. ii) Brightfield image at peak contraction. iii) Result image of 
reference frame subtracted from non-displaced frame. iv) Result image from reference image 
subtracted from frame at maximum displacement. B) Example output showing train of contractions. 
E) Visual breakdown of the parameters obtained from contraction analysis. The upstroke time 
(Up90 red) and downstroke time (Dn90 blue) are output alongside the contraction duration (CD) at 
10,50,75 and 90% peak contraction. 
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Using the exposure time of the frames of interest, several contraction 
parameters can be determined. The beat-to-beat cycle length along with the 
duration of the upstroke (Up90 – time from 10% contraction to peak contraction) 
and downstroke (Dn90 – time from peak contraction to 10% contraction) phases 
of contraction can be determined. The cycle durations at various levels of 
contraction are also output by the algorithm (e.g. CD50 – time for 50% 
contraction after peak minus time for 50% contraction before peak) (Figure 2.3). 
As contraction amplitude is relative, and therefore heavily influenced by 
changes in light intensity and cell position, it was not used for the majority of 
experiments. 
MUSCLEMOTION has been validated against gold standards in several cell systems 
(optical flow measurements in hiPSC-CMs, post deflection in engineered heart 
tissues, and sarcomere length fractional shortening in adult cardiomyocytes). 
MUSCLEMOTION correlated well with optical flow in isolated hiPSC-CMs (R2 = 
0.916) (Figure 2.4a v), hiPSC-CM monolayers (R2 = 0.803)(Figure 2.4b v) and 
hiPSC-derived cardiac organoids (R2 = 0.747) (Figure 2.4c v). MUSCLEMOTION also 
correlated well with post deflection in engineered heart tissues (R2 = 0.879) 
(Figure 2.4d v) and sarcomere length fractional shortening for adult rabbit 
ventricular cardiomyocytes (R2 = 0.871) (Figure 2.4e v)125. 
Throughout this project, for consistency and accuracy, only areas of iPSC-CM 
monolayers that showed heterogeneous contraction upon manual observation 
were recorded and analysed using the MUSCLEMOTION algorithm. The typical 
distribution of contractility parameters obtained throughout this project are 
shown in Figure 2.5. Spontaneous cycle length was not normally distributed with 
greater than 90% of cells having spontaneous frequency between 0.5 and 3Hz. As 
Up90, Dn90 and contraction durations are heavily influenced by the beating rate 
of cells, they also displayed non-normal distributions. 
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Figure 2.4 Correlation of results with gold standards 
Figure and caption obtained from Sala et al125. a) Brightfield image of isolated hiPSC-CMs (i), with 
maximum projection step visually enhanced with a fire Look Up Table (ii), contraction (iii) and 
velocity (iv) profiles of each individual beat have been generated by MUSCLEMOTION and 
temporally aligned; linear regression analysis between MUSCLEMOTION results (x-axis) and 
optical flow results (y-axis) (v). b) Phase contrast image of hiPSC-CM monolayers (i), with 
maximum projection step visually enhanced with a fire Look Up Table (ii), contraction (iii) and 
velocity (iv) profiles of each individual beat have been generated by MUSCLEMOTION and 
temporally aligned; linear regression analysis between MUSCLEMOTION results (x-axis) and those 
obtained with optical flow results (y-axis) (v). c) Phase contrast image of cardiac organoids (i), with 
maximum projection step visually enhanced with a fire Look Up Table (ii), contraction (iii) and 
velocity (iv) profiles of each individual beat have been generated by MUSCLEMOTION and 
temporally aligned; linear regression analysis between MUSCLEMOTION results (x-axis) and those 
obtained with optical flow results (y-axis) (v). d) Live view of an EHT during contraction analysis. 
Scale bar = 1 mm. (i), with maximum projection step visually enhanced with a fire Look Up Table 
(ii), contraction (iii) and velocity (iv) profiles of each individual beat have been generated by 
MUSCLEMOTION and temporally aligned; linear regression analysis between MUSCLEMOTION 
results (x-axis) and those obtained with post deflection (y-axis) (v). e) Brightfield image of adult 
rabbit CMs (i), with maximum projection step visually enhanced with a fire Look Up Table (ii); 
contraction (iii) and velocity (iv) profiles of each individual beat have been generated by 
MUSCLEMOTION and temporally aligned; linear regression analysis between MUSCLEMOTION 
results (x-axis) and those obtained from sarcomere fractional shortening calculation with Fast 
Fourier Transform (y-axis) (v). 
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Figure 2.5 Typical variation in spontaneous contractility parameters 
Histograms showing distribution of spontaneous measurements of A) Up90, B) Dn90, C) CD90, D) 
CD75, E) CD50, F) CD10 and G) Cycle length. N = 240 cell areas. 
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2.2.5 Optical dyes 
2.2.5.1 Di-4-anepps 
Di-4-anepps is a voltage sensitive dye with a peak excitation of 482 nm (Figure 
2.6) and peak emission of 686 nm. Using photomultiplier tubes (PMTs) to detect 
emissions from either side of the peak, ratiometric voltage measurements can 
be performed. Membrane depolarisation causes a reversible change in peak 
emission towards a shorter wavelength. When this occurs, the signal from the 
short wavelength PMT increases while the signal from the long wavelength PMT 
decreases. The ratio of these two signals can be used to monitor changes in 
membrane potential and give several useful metrics such as various action 
potential durations. Ratiometric dyes such avoid several of the artefacts 
(movement, photobleaching) that plague non-ratiometric dyes such as fluovolt, 
however the imaging equipment required is more complex. The photostimulation 
apparatus (Figure 2.1) was adapted from the system used for voltage 
measurements. As channelrhodopsin-2 and di-4-anneps share similar excitation 
spectra (Figure 2.6), di-4-anneps could not be used in conjunction with 
photostimulation. 
2.2.5.2 Fura-2 
Fura-2 is a ratiometric calcium indicator that can be calibrated to give optical 
measurements of absolute calcium levels. Unlike voltage measurement with di-
4-anepps, which excites at 1 wavelength and monitors 2 emission wavelengths, 
calcium measurements with fura-2 excites with 2 wavelengths, typically 340 nm 
and 380 nm, and records emission at 1 wavelength, typically 510 nm (Figure 
2.6). When excited at 340 nm an increase in free calcium concentration causes 
an increase in fluorescence but causes a decrease in fluorescence when excited 
at 380 nm. The fluorescence ratio of 340/380 increases linearly with increasing 
calcium concentration (0-3000 nm) and independently of fura concentration126. 
While measurement of cytoplasmic calcium levels would be useful for this 
project it was unclear how 340 or 380 nm illumination will interact with 
channelrhodopsin-2 as action spectra for the ion channel have not been recorded 
at wavelengths shorter than 390 nm127 
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Figure 2.6 Excitation spectra for Di-4-anepps, Fura-2 and ChR2 
Excitation and emission spectra for Di-4-Anepps, Fura-2 (calcium bound) and Fura-2 (calcium free) 
were obtained from thermofisher spectraviewer. Spectra for Channelrhodopsin-2(H134R mutant) 
recreated from Lin et al127 supplemental material. 
2.2.6 Cell fixing 
Cell media was removed and replaced with 2% paraformaldehyde (PFA) in PBS. 
The PFA was removed after ten minutes and the cells were washed 3 times in 
PBS. Fixed cells were then stored at 4°C for a maximum of 3 weeks before being 
used for immunohistochemistry. 
2.2.7 Immunohistochemistry 
Fixed cells were placed in a 0.2% triton 1% BSA PBS solution for 10 minutes in 
order to permeabilise the cells. They were then washed for 10 minutes in 1% BSA 
PBS 3 times before being blocked for an hour with a 10% goat serum, 1% BSA PBS 
solution. After blocking, cells were washed once for 10 minutes using 1% BSA 
PBS. The cells were then covered with a PBS solution containing 3% goat serum, 
1% BSA and 0.2% mouse anti-α-actinin primary antibody (Invitrogen) and stored 
at 4°C overnight. After primary staining was completed the cells were washed 3 
times in 1% BSA PBS before being covered with a secondary antibody PBS solution 
containing 1% BSA and 0.5% goat anti-mouse alexafluor 647 secondary antibody 
for 1.5 hours. Cells were then washed with standard PBS 3 times before imaging. 
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2.2.8 Cell imaging 
Stained cells were placed on an Olympus IX83 confocal microscope under 40x 
magnification. 40x magnification was used to allow sarcomeres to be resolved 
while avoiding the application of lens oil required at higher magnification. The 
focal point was found using brightfield illumination before illumination was 
switched to 637 nm laser light (Obis continuous wave laser, Coherent, USA) with 
a 700/75 nm emission filter for visualisation of α-actinin. 561 nm laser light 
(Obis continuous wave laser, Coherent, USA) with a 595/50 nm emission filter 
was used for visualisation of mCherry (Figure 2.7). A Cairn research opto-spin 
filter controller was used to change emission filters. Minimal laser power was 
used in order to prevent significant photobleaching and a standard exposure 
time of 200 ms and an EM gain of 300 was used for the majority of images but 
was adjusted if required. Due to the nature of the cellular monolayer, it was 
often the case that the full sarcomere could not be imaged in a single focal 
plane. As long as the distance between the top and the bottom of the sarcomere 
was small (<10 µm) a z-stack of the sarcomere area was taken. Using Metamorph 
imaging software, the IX83s focus motor (to allow fine automated control of the 
height of the objective lens) and an Evolve 512 Delta EMCCD camera 
(Photometrics, USA), a series of images at varying points on the z axis but fixed 
points on the x and y axis was acquired. Focal depth was controlled using an X-
light confocal imager with a 70 µm pinhole disc spinning at 1500rpm (Crest, 
Italy) The resulting “z-stack” was then used in a maximum intensity projection 
to increase the usable area of α-actinin. Only those cells with clearly defined 
sarcomeres, that had no overlapping cells were selected for analysis. 
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Figure 2.7 Optical pathway for confocal microscope 
Optical pathway diagram showing microscope set-up used for visualisation of α-actinin and 
mCherry. 637 nm laser light was used in conjunction with a 700/70 nm emission filter for 
visualisation of α-actinin while 561 nm illumination and a 595/50 nm emission filter was used to 
visualise mCherry. 
2.2.9 Image analysis 
FIJI128 (an open-source image analysis software) was used to determine 
sarcomere length, inhomogeneity and alignment. Sarcomere images first had 
their background subtracted using a rolling ball radius of 2.0. Areas of usable 
sarcomere were selected, and the image was manually thresholded to produce a 
binary image. The FIJI plugin “Skeletonise 2d/3d” was used to produce a 
skeletonised image. Another FIJI plugin, “Directionality”, was used to determine 
the sarcomere alignment from the skeletonised image (Figure 2.1 E). This 
method was adapted from a t-tubule analysis method129. Sarcomere length and 
inhomogeneity were determined by applying a fast Fourier transform (FFT) to 
the skeletonised sarcomere image. The resulting spatial frequency was then 
plotted (Figure 2.8 D) and the sarcomere length was determined by taking the 
reciprocal of the fundamental frequency, whereas the sarcomere inhomogeneity 
was taken as the full width at half maximum of the first order peak (FWHM)130. A 
1 mm stage micrometer with 0.1 and 0.01 mm divisions was used as a to confirm 
results. 
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Figure 2.8 Sarcomere analysis 
Example images of sarcomeric analysis. A) 0.01 mm stage micrometer divisions, B) Fourier 
transform of stage micrometer image. C) α-actinin staining in i) an iPSC-CM and ii) an adult rat 
ventricle cell. D) show the resulting Fourier transform which was then used to calculate sarcomere 
length (FF= fundamental frequency) and inhomogeneity (FWHM= full-width half maximum) in i) 
iPSC-CMs and ii) adult rat ventricle cells. E) Output of the ImageJ Directionality plugin that was 
used to quantify sarcomere alignment in i) iPSC-CMs and ii) adult rat ventricle cells. 
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2.2.10 Commercially available iPSC-CMs have a markedly 
different sarcomeric structure from isolated adult 
cardiomyocytes 
 
Figure 2.9 Baseline comparison of cell structure 
Sarcomere length was significantly longer in adult cardiomyocytes (N= 3 animals, 10 cells/animal) 
when compared to iPSC-CMs (N=4 wells, 10 cells/well) (1.766 ± 0.017 µm vs 2.028 ± 0.079 µm 
respectively, P=0.0125 unpaired t-test). Middle) Sarcomere inhomogeneity in iPSC-CMs was 
comparable to adult cells (0.39 ± 0.035 µm vs 0.28 ± 0.046 µm respectively, P=0.1024). Right) 
adult cardiomyocytes are vastly more polarised than iPSC-CMs (4.98 ± 0.44° vs 25.22 ± 3.15° 
respectively, P=0.0029 unpaired t-test). 
Fourier analysis of the 0.1 mm stage micrometer divisions gave a length of 100 
µm while the 0.01 gave a length of 10 µm. iPSC-CMs had a significantly shorter 
sarcomere length, when compared to isolated adult rat ventricular cells (1.766 ± 
0.017 µm vs 2.028 ± 0.079 µm respectively, P=0.0125 unpaired t-test. Figure 
2.9). The sarcomere inhomogeneity however, was not significantly different 
between the iPSC-CMs and the adult ventricle cells (0.39 ± 0.035 µm vs 0.28 ± 
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0.046 µm respectively, P=0.1024. Figure 2.9). By far the starkest contrast 
between the iPSC-CMs and adult cells was the sarcomere alignment. The spatial 
frequency spectra of the mainly circular iPSC-CMs covers a much larger range of 
angles (25.22 ± 3.15°) than the polarised adult cardiomyocytes (4.98 ± 0.44°, 
P=0.0029, unpaired t-test. Figure 2.9). These results are the baseline 
measurements that were used throughout this project and are discussed in detail 
in chapter 4. 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 3: Optimisation and validation of 
channelrhodopsin based photostimulation 
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3.1 Introduction 
3.1.1 Axiogenesis Cor4U 
Cor4U cells are an iPSC-CM cell line generated by Axiogenesis using the 
Yamanaka method of generating iPSC from dermal fibroblasts40. Human 
Fibroblasts (from a 28-year-old Caucasian female donor) were used to generate 
iPSC cells via virus-free plasmid transfection. Two vectors were used for 
transfection, each containing two of the pluripotency-associated genes Klf4, c-
Myc, Oct3/4 and Sox2. Vectors I and II were approximately 8kb and 7kb in size, 
with a beta-actin promoter. Cardiomyocyte differentiation was driven by a 9.5kb 
plasmid vector which was used to insert the cardiomyocyte specific alpha MHC 
promotor and the puromycin resistance cassette. The antibiotic resistance this 
conferred was used to increase the purity of the cardiomyocyte culture to 100%. 
Due to their human background they are an ideal substrate for cardiotoxic drug 
testing131. These cells however do demonstrate many of the disadvantages 
associated with their immature phenotype132.  
3.1.2 Channelrhodopsin-2 
ChR-2 is a light-gated cation channel derived from the green algae 
Chlamydomonas reinhardtii108. The H134R gain of function variant used in this 
project arises from a single point mutation from histidine to arginine at histidine 
residue 134 which results in an increased photocurrent109. 
Peak photocurrent occurs at 450 nm illumination however approximately 60% 
peak current can be induced by 390 nm light127.The blue shifted activation 
spectra allows channelrhodopsin expressing cells to be optically paced using a 
470 nm led normally used for voltage sensitive dyes. This also means that 
illumination with 470 nm light with sufficient intensity to fluoresce such optical 
dyes would also activate channelrhodopsin meaning photostimulation and optical 
voltage sensing may be incompatible. Data regarding activation at shorter 
wavelengths could not be found, however it is possible that illumination with 
380, or 340 nm, the illuminations used by ratiometric calcium dyes such as fura, 
could cause a photocurrent to be injected and alter cell electrophysiology. 
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3.1.3 Strength duration curve 
 
Figure 3.1 Plasma membrane equivalent circuit diagram 
Equivalent circuit diagram representing a patch of plasma membrane. Cm represents the 
membrane capacitance, Rm represents the membrane resistance to ion flux, and Vm represents the 
potential difference across the membrane. 
The membrane of an excitable cell can be represented, somewhat simplistically, 
by an electric circuit diagram. The impermeant nature of the plasma membrane 
causes it to act like a capacitor (Cm), while the restricted flow of ions through 
ion channels acts like a resistor (Rm). Differences in ion concentrations between 
the intracellular and extracellular solutions cause opposing charges to build up 
either side generating a potential difference across the membrane (Vm). At rest, 
this potential difference is maintained by and can be calculated using the 
Goldman-Hodgkins-Katz equation (Equation 3.1) and is approximately -90mV in 
ventricular cells. 
Equation 3.1 Goldman-Hodgkin-Katz equation 
Where EM is the resting membrane potential, R is the universal gas constant, T is the absolute 
temperature in kelvin, F is the Faraday constant, P is the relative membrane permeability to ion x 
[x]o is the extracellular concentration of ion x and [x]i is the intracellular concentration of ion x. 
𝐸𝑀 =
𝑅𝑇
𝐹
ln (
𝑃𝑁𝑎+[𝑁𝑎
+]𝑜 + 𝑃𝐾+[𝐾
+]𝑜 + 𝑃𝐶𝑙−[𝐶𝑙
−]𝑖
𝑃𝑁𝑎+[𝑁𝑎+]𝑖 + 𝑃𝐾+[𝐾+]𝑖 + 𝑃𝐶𝑙−[𝐶𝑙−]𝑜
) 
 
When an inward current is injected into the cell, the membrane potential 
becomes depolarised. When the membrane potential reaches a certain value, 
voltage-sensitive Na+ ion channels open causing an inward current further 
depolarising the membrane and initiating an action potential. The membrane 
potential this occurs at is referred to as the threshold potential. To reach 
threshold potential the current stimulus (I) must supply sufficient charge (Q) 
within the duration (t) of the stimulus (𝐼 = 𝑄 𝑡⁄ ). The charge required is 
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determined by the threshold potential (Vt) and the capacitance (C) of the cell 
membrane (𝑄 = 𝑉𝑡𝐶). The threshold current (It) is therefore directly related to 
the cell capacitance and threshold potential (𝐼𝑡 =
𝑉𝑡𝐶
𝑡⁄ ). Assuming capacitance 
and threshold potential are fixed, the threshold current is inversely related to 
the duration of the stimulus (𝐼𝑡 =
1
𝑡⁄ ) giving rise to the strength-duration curve 
(Figure 3.2(A)) from which, 2 useful cell characteristics can be determined. 
Rheobase, the minimum current required to reach threshold with a stimulus 
pulse of infinite duration, and chronaxie, the duration of a pulse with twice the 
rheobasic strength.  
The strength-duration curve, although it has limitations7, is a useful tool for 
comparing the excitability of different tissues and has been used to show 
excitability changes in response different drugs. Both chronaxie and rheobase 
have been shown decrease upon the addition of caffeine (likely due to 
sensitisation of RyR2 as well as indirect effects on calcium channels due to 
phosphodiesterase inhibition)133, and increase upon exposure to quinidine134,135, 
bunapthine136 and propafenone137. Strength duration curves have also been used 
to show the effect of denervation on the excitability of skeletal muscle. 
Denervation of rabbit limb muscle caused a transient increase in rheobase that 
normalised overtime, this was accompanied by a permanent increase in 
chronaxie demonstrating the reduction in excitability caused by degeneration of 
the motor endplates138. 
In the context of this project, the strength-duration curve is useful as it allows 
for iPSC-CM excitability to be compared between ChR-2 and field stimulation, as 
well as revealing any changes in excitability caused by chronic photostimulation. 
3.1.4  Aims 
The aims of this chapter were to: 
1) Determine optimal virus load for effective ChR-2 transfection in iPSC-CMs 
2) Assess equivalence of optogenetic and field stimulation in iPSC-CMs  
3) Assess feasibility of using optical dyes in conjunction with optogenetics. 
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Figure 3.2 Example strength-duration curve 
Figure obtained from Geddes et al102. A) Lapicque hyperbolic strength-duration (d) curve for current 
(I) and the Weiss linear strength-duration relationship for charge Q=Id. B) universal strength-
duration curves, plotted logarithmically, for current energy and charge, with the duration axis 
divided by c, the chronaxie. 
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3.2 Methods 
3.2.1 Optical power calibration 
A Thorlabs s120vc power meter was used to determine the optical power 
produced by different voltages on the external Digitimer stimulator. Voltage was 
then plotted against power and the equation of the best fitting line was used to 
allow conversion of stimulation voltage into optical power. The area of the field 
of view of the 40x objective was ascertained using a stage micrometer allowing 
optical power to be converted into optical power per unit area, the standard 
unit for use in optogenetics116,123,139,140 
3.2.2 Cell Plating 
Stem cell derived cardiomyocytes (Axiogenesis) were seeded onto fibronectin 
(1:100 PBS) coated, Mattek 96 well glass bottomed plates at a density of 25,000 
cells per well.  
3.2.3 Viral Transfection 
After 1 day in vitro (DIV) cells were incubated overnight with an adeno-
associated virus containing ChR2 (Addgene# 20938M obtained from Vector 
Biolabs, Pennsylvania) at a multiplicity of infection (MOI) of 1250, 2500, 5000, 
10,000, and 20,000 
3.2.4 Time course for responsiveness 
Each day post transfection, 3 randomly selected regions within each well were 
excited with 2 Hz 2 ms 470 nm light at an optical power of 1.6 mW/mm2. The 
number of responsive regions was recorded until day 5 post-transfection. 
3.2.5 Threshold Recordings 
Cells were stimulated at 2 Hz with a pulse width of 2 ms using opto-led light at 
470 nm the power of which was reduced using a 10% neutral density filter. Cell 
contractions were recorded using a Hamamatsu orca flash 4.0 camera attached 
to an Olympus IX71 Microscope at 40x magnification. The minimum optical 
power required to achieve 1:1 coupling was recorded for each MOI (Figure 3.3).  
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Figure 3.3 Optical thresholding 
Demonstration of optical thresholding technique. Contractility (black trace) is monitored while 
optical power (represented by blue spikes) is gradually increased until 1:1 
photostimulation:contraction coupling is achieved.  
3.2.6 Chronaxie determination 
Responsive cells were excited at 2 Hz with a 480 nm opto-led and the threshold 
for response measured at 0.2, 0.3, 0.5, 0.7, 1, 2, 3, 5, 7 and 10 ms pulse widths. 
Control cells were stimulated with solid state electrodes at the same frequency 
and pulse widths. Strength duration curves were best fitted (R2 > 99%) with a 
second order exponential decay function (Figure 3.4). 𝑦0 was used as the 
rheobasic current and the pulse width corresponding to a threshold current of 
twice the rheobase was taken as the chronaxie. 
Optical chronaxie and rheobase were determined automatically in later chapters 
using a Python program developed in house to first convert Digitimer stimulator 
voltage into optical power, and then plot and fit the strength duration curve 
(see appendix). 
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Figure 3.4 Strength duration curve fitting 
Optical strength duration curves fit with A) simple inverse function (𝐼𝑡 =
1
𝑡⁄ ), B) Lapicque 
hyperbolic function102 (𝐼 = 𝑏 (1 +
𝑐
𝑑
)) C) Lapicque 1st order exponential decay141 (𝐼 =
𝑏
(1−𝑒
−𝑐
𝑑 )
) and 
D) 2nd order exponential decay (𝑦 = 𝐴1𝑒
−𝑥
𝑡1 + 𝐴2𝑒
−𝑥
𝑡2 + 𝑦0). 
 
3.2.7 Determining viability of optical dyes 
Cell contractility of transfected cells was recorded whilst illuminating  
constantly with 470 nm (2.11 mW/mm2), 380 nm (0.45 mW/mm2), or 340 nm 
(0.33 mW/mm2) light at levels used for imaging with optical dyes. Similar 
recordings were performed every ten minutes over a 30-minute period to 
determine baseline variations in contractility values under only brightfield 
illumination.  
3.2.8 Statistics 
One-way ANOVA or two sample t-tests were used where appropriate. Data are 
displayed as the mean plus standard error of the mean. P<0.05 was taken as 
significant. 
Chapter 3 57 
 
3.3 Results 
3.3.1 Voltage and optical power are linearly related 
Optical power was linearly related to stimulator voltage with the equation Y= 
201.6X – 7.293(Figure 3.5). With a minimum optical power of 1.5µW and a field 
of view of 0.246 mm2 the minimum optical power available was 0.006 mW/mm2 
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Figure 3.5 Optical power calibration 
Optical power through the 40x objective lens is linearly corelated with the voltage supplied through 
the stimulator box with the equation Y = 201.6X – 7.293. 
3.3.2 At 5 days post-transfection cells were fully responsive 
Immediately after removal of adeno-associated virus, until 2 days post-
transfection, cells showed no response to optical stimulation regardless of the 
MOI used. At 2 days post-transfection several areas within wells transfected at 
an MOI of 2500 and above responded to stimulation, however there were still 
unresponsive areas within these wells. By day 3 all conditions had responsive 
areas with cells transfected at MOI’s of 10000 and 20000 showing 100% 
responsiveness to stimulation. The percentage of areas responding to stimulation 
continued to increase with cells transfected at an MOI of 5000 reaching 100% 
responsiveness at 3 days post-transfection and those transfected at an MOI of 
2500 reaching 100% responsiveness at 4 days post-transfection. Cells transfected 
at an MOI of 1250 did not reach 100% responsiveness by the time the experiment 
was concluded (Figure 3.6A). The threshold value of the responsive areas at day 
5 did not differ significantly between the transfection groups (Figure 3.6B, 
unpaired 1-way anova).  
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Figure 3.6 Cell responsiveness over time 
A) cells began responding to stimulus at 2 days post-transfection and the percentage of areas 
responding increased to 100% at, 3 days post transfection in cells transfected at MOI’s of 10000 
and 20000, 4 days post-transfection for cells transfected at MOI 5000 and 5 days post-transfection 
at 2500 MOI. B) At 5 days post-transfection there was no significant differences in threshold within 
responsive areas between transfection groups.  
3.3.3 Optical and electrical excitability is comparable. 
The chronaxie for optical stimulation (1.53 ± 0.32 ms N=9) was not significantly 
different from the chronaxie of traditional electrical stimulation (2.17 ± 0.44 ms 
N=9, P=0.2434 unpaired t-test) (Figure 3.7D). 
 
Figure 3.7 Photostimulation validation 
A) Example of strength-duration curve showing rheobase, 2x rheobase and chronaxie time. B) 
Example of strength-duration curve obtained using optical stimulation at 2 Hz with an MOI of 2500. 
C) Example of strength-duration curve obtained using electric field stimulation. D) No significant 
difference in chronaxie between optical and field stimulation (N = 9 wells). 
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3.3.4 Continuous illumination with 470 nm light drastically alters 
cell contractility 
Continuous 470 nm illumination caused a significant decrease in contraction 
amplitude (Table 3.1, Figure 3.8). Cycle length, Up90, and Dn90 were not 
significantly changed by 470, 380, and 340 illumination. The spread (max value-
min value) of data was much larger upon 470 illumination compared to the 
spread caused by time (Table 3.1, Figure 3.10). The spread of data under 380 
and 340 nm illumination was less than the spread under 470 nm illumination, 
however it was still larger than the spread of data after 30 minutes (Table 
3.1,Figure 3.10).  
 
Figure 3.8 Change in cell function during continuous illumination 
Demonstration of the spread of values recorded in i) spontaneous cycle length, ii) contraction 
amplitude, iii) Up90 and iv) Dn90 that occurred upon illumination with 470, 380, and 340 nm light. 
470 nm light caused a significant decrease in contraction amplitude (404.1 ± 40.1 vs 195.0 ± 37.5, 
P = 0.0076) and increased the spread of data in all parameters recorded N = 11 cell areas. 
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Figure 3.9 Change in cell function over 30 minutes 
Demonstration of the spread of values recorded in i) spontaneous cycle length, ii) contraction 
amplitude, iii) Up90 and iv) Dn90 that occurred over 30 minutes. N = 10 cell areas 
 
Figure 3.10 Change in cell function during continuous illumination 
Demonstration of the spread of values recorded in i) spontaneous cycle length, ii) contraction 
amplitude, iii) Up90 and iv) Dn90 that occurred upon illumination with 470, 380, and 340 nm light 
(Figure 1.8) compared to the variation over time (Figure 1.9). 470 nm light had a significant effect 
on average contraction amplitude but increased the spread of data in all parameters recorded. The 
range of values observed is displayed in section C).  
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Table 3.1 Change in cell function during continuous illumination 
Spread of contractility parameters represented by the range of values shown in Figure 3.10  
 470 nm 380 nm 340 nm 30 minutes 
recovery Cycle length 62.97 18.14 20.36 13.47 
Amplitude 69.48 19.14 17.07 14.24 
Up90 158.72 40.02 17.02 16.35 
Dn90 137.70 26.69 26.17 8.00 
 
3.4 Discussion 
3.4.1 At 5 days post-transfection cells were fully responsive 
Time course and threshold results reveal that, as MOI does not affect stimulation 
threshold, the optimal transfection protocol was an MOI of 2,500 allowing 
photostimulation at 5 days post-transfection. Although a higher MOI would allow 
100% responsiveness to be reached sooner, a lower MOI was chosen to prevent 
waste. This protocol was used for all following photostimulation experiments. 
3.4.2 Optical and electrical excitability is comparable. 
The chronaxie for ChR-2 stimulation has previously been shown to be 
approximately 4 ms in isolated rat cardiomyocytes142, and 5-7 ms for intact 
mouse hearts140. The chronaxie for cathodal stimulation of intact rat hearts has 
been shown to be 0.8-0.9 ms143, 0.2-0.5 ms for field stimulation in neonatal rat 
heart constructs144, and 1.8 ms for field stimulation in isolated adult rat 
cardiomyocytes145. Modelling of optogenetic and electrical stimulation in human 
cardiomyocytes shows a preservation of action potential morphology between 
ChR-2 stimulation and direct electrical current injection, although differences in 
current waveform meant that the corrected chronaxie for optical stimulation 
was 18 ms compared to 8 ms for electrical stimulation146. 
Taken together these results indicate that muscular systems are less sensitive to 
optogenetic stimulation than they are to electrical stimulation. However, to the 
authors knowledge, no other study has performed a direct comparison between 
field stimulation and ChR-2 stimulation within the same cells. Within this 
chapter, chronaxie values did not differ significantly between electrical and 
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optogenetic stimulation, indicating that iPSC-CMs are equally excitable by ChR-2 
and field stimulation. 
3.4.3 Continuous illumination with 470 nm light drastically alters 
cell contractility 
For an optimal signal-to-noise ratio, voltage measurements using di-4-anneps or 
fluovolt use 470 nm illumination at an intensity of 2.11 mW/mm2, far above the 
threshold intensity for optical pacing (Figure 3.6b). As 470 nm illumination is 
close to the peak excitation of ChR-2127, continuous supra-threshold illumination 
led to a significantly reduced contraction amplitude and disrupted other 
contraction parameters (Figure 3.8) above the normal variation in these cells 
(Figure 3.9). A consequence of this is that the optical voltage sensors used in 
house are incompatible with ChR-2 based optogenetic pacing. Recent work has 
shown that the red shifted voltage sensor di-4- ANBDQPQ allows voltage 
measurements alongside optical pacing with ChR-2 in mouse hearts147. 
Unfortunately, adapting the optical platform used in this project to allow use of 
red shifted dyes was out with the scope of this project due to time and cost 
restraints. 
Although there were no significant changes in cell contractility, there was also 
minor disruption of contraction upon 380 nm illumination. As shown previously 
(Figure 2.6), the action spectra for ChR-2 shows current injection at wavelengths 
as low as 390 nm. It is therefore likely that illumination with 380 nm causes a 
current injection that is below the threshold for action potential generation, but 
large enough to disrupt action potential, and subsequently contraction 
morphology. In future studies the use of red shifted voltage sensitive dyes could 
be used to test this hypothesis. 
3.4.4 Conclusions 
Photostimulation is a valid alternative to solid state electrical stimulation 
however it is incompatible with standard fluorescent voltage or Ca2+ indicators. 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 4: Initial trial of chronic pacing 
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4.1 Introduction 
Chapter 3 demonstrated that the introduction of channelrhodopsin-2 into 
Axiogenesis iPSC-CMs allows the endogenous rate of the cells to be overridden by 
photostimulation. This chapter shall attempt to determine whether this 
alteration of contraction frequency can be used to induce a phenotypic change. 
Controlling the beating rate of iPSC-CMs via electrical stimulation has been 
shown to induce phenotypic changes associated with an increase in maturity48-50. 
Continuously overriding the endogenous rhythm of iPSC-CMs for a period of 
several days has also been shown to have lasting effects on iPSC-CM 
electrophysiology51,148. An interesting aspect of electrical stimulation is the 
electrolysis of extracellular solutions leading to generation of reactive oxygen 
species (ROS)149,150. Given that it has been shown that application of ROS can 
itself induce phenotypic changes in embryoid bodies47, it is possible that the 
phenotypic changes observed following electrical stimulation could be due to 
ROS. There is little evidence suggesting that optogenetic stimulation via 
channelrhodopsin-2 results in the generation of ROS. 
The long-term goal of this project was to replicate the electrical conditions 
found in the early stages of cardiac development. This entails replicating a 
directional action potential spread for a period of several days. Before the 
directionality can be replicated it must be demonstrated that photostimulation 
can be maintained for the appropriate length of time.  
4.1.1 Aims 
This chapter aimed to: 
1) Determine whether photostimulation can be maintained for an extended 
period.  
2) Identify phenotypic changes occurring as a result of extended 
photostimulation. 
3) Identify any issues that may hinder application of the photostimulation 
protocol. 
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4.2 Methods 
4.2.1 Cell plating 
Cells were plated in Mattek, glass bottomed 35 mm petri dishes at a density of 
25,000 per well as described previously. 
4.2.2 Viral transfection 
Cells were transfected at an MOI of 2,500 and were ready for use 1 week after 
plating as described in chapter 3. 
4.2.3 48-hour pacing 
Petri dishes containing transfected cells were moved to an Okolab stage 
incubator mounted upon an Olympus IX71 microscope. A central location of 
beating cells was located using 40x magnification. This central area was then 
stimulated at 2 Hz with a pulse width of 2 ms for a period of 48 hours using a 470 
nm led at 10% above pacing threshold power. Contractility recordings and 
strength-duration curves were taken at the beginning and end of the 48-hour 
period. 
4.2.4  48-hour multi-site pacing 
To reduce the total amount of photostimulation delivered to a single site, In-
house software was used to move photostimulation between 6 peripheral sites 
per well by moving the stage to predetermined sites. Sites were photostimulated 
at 2-3 Hz with a 2 ms pulse width for 100 seconds. Photostimulation was 
alternated between 2 adjacent inserts to allow concomitant photostimulation 
with a duty cycle of 50% (Figure 4.1). Contractility recordings and strength 
duration curves were taken before and after pacing. Cells were then fixed using 
2% paraformaldehyde (PFA). 
4.2.5 96-hour multi-site pacing 
Using the same protocol as before, cells were paced for 96 hours and cell media 
was replaced every 48 hours. At the end of the 96 hours, photostimulation was 
stopped and the cells were rested for 24 hours. Contractility recordings and 
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strength duration curves were taken at 0,48 and 96 hours of pacing. To identify 
any lasting effect of photostimulation, recordings were also taken after the 24-
hour rest period. The cells were once again fixed at the end of the experiment.  
 
Figure 4.1 Multi-site pacing protocol 
A) Timeline for 96-hour pacing. B) Figure representing order and position of photostimulation sites 
across 2 wells within a 35 mm glass bottomed petri dish. C) Mock timeline demonstrating the 50% 
duty cycle with each block representing 100 seconds of photostimulation. D) Total pacing and rest 
times for each stimulation site over 48 and 96 hours. 
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4.2.6 Study endpoints 
To identify any issues with the chronic pacing protocol, several parameters were 
studied before and after pacing. The spontaneous cycle length and contraction 
kinetics such as the Up90, Dn90, CD10, 50 and 90 served as markers of cell 
function and were obtained within 30 seconds of the cessation of 
photostimulation. Details of contractility parameters can be found in chapter 2. 
Sarcomere length, inhomogeneity and alignment served as markers of cell 
structure, details of their acquisition can be found in chapter 2. 
4.3 Results 
4.3.1 Chronic pacing at a single site causes cell death 
Chronic pacing at an individual sight caused cell damage within 24 hours and loss 
of coupling and cell death within the photostimulation area within 48 hours. 
Further pacing experiments utilised a patterned photostimulation protocol. 
Initial experiments demonstrated that a 100% duty cycle still proved toxic, 
however a 50% duty cycle was well tolerated over 96 hours by trial cells. The 
toxic effect of photostimulation is studied in detail in chapter 5. 
4.3.2 48 hours of patterned photostimulation caused changes in 
spontaneous rate 
There were no changes in the chronaxie times or rheobasic currents obtained 
from the strength duration curves (Figure 4.2) taken before and after 48 hours of 
2 Hz pacing, indicating that cell excitability was not altered significantly. 2 Hz 
pacing also had no effect on the contraction upstroke or downstroke (Figure 
4.2). The spontaneous cycle length (Figure 4.4) and sarcomere length, 
inhomogeneity and dispersion (Figure 4.3) were also unchanged by chronic 
pacing at 2 Hz. 
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Figure 4.2 Cell functionality after photostimulation period (48 hours) 
Functional measurements acquired before and after 48 hours of 2 Hz photostimulation. There was 
no change in the chronaxie after 48 hours of photostimulation, the rheobasic optical power 
remained unchanged by pacing. Up90 and the dn90 were not influenced by the photostimulation 
protocol (N = 6 wells).  
Initial experiments increasing the photostimulation frequency to 3 Hz had no 
effect on contraction kinetics, but significantly increased the spontaneous cycle 
length (Figure 4.4). 3 Hz photostimulation for 48 hours caused the spontaneous 
cycle length to increase from 576 ± 79 ms to 2258 ± 608 ms (P= 0.021 unpaired t-
test). 
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Figure 4.3 Cell structure after photostimulation period (48 hours) 
Sarcomeric measurements comparing control, paced (N = 4 wells, 10 cells/well) and adult (rat 
ventricle, N= 3 animals, 10 cells/animal) cells. There were no changes associated with pacing in 
sarcomere length, sarcomere inhomogeneity or sarcomere alignment. The iPSC-CM’s remained 
significantly different to adult myocytes in all 3 metrics. * P≤0.05, ** P≤0.01, *** P≤0.001 (1-way 
ANOVA)  
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Figure 4.4 Spontaneous cycle length after photostimulation period (48 hours) 
Measurements of spontaneous activity of iPSC-CM’s. The cycle length of spontaneous 
contractions remains unchanged following 48 hours of 2 Hz photostimulation, however 48 hours of 
3 Hz photostimulation caused a significant increase in the spontaneous cycle length (N = 6 wells).  
* P≤0.05 (paired t-test) 
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4.3.3 96 Hours of patterned photostimulation at 3 Hz caused 
changes in cell function and structure. 
There were no changes in markers of cell excitability both during and following 
the photostimulation protocol (Figure 4.5). The spontaneous cycle length was 
significantly increased after 48 (868.8 ± 143.2 ms to 5709 ± 1293 ms P=0.0245 
repeated measures one-way ANOVA) and 96 hours of pacing (1931 ± 190.8 ms 
P=0.0062 repeated measures one-way ANOVA) but returned to prepacing values 
after the 24-hour rest period (Figure 4.6).  
Measurements of contraction kinetics were complicated by an artefact 
generated by the stimulus light masking the contractility trace making analysis 
of paced traces impossible. Therefore, the recordings of spontaneous activity in 
the paced areas were analysed. There were no significant changes in the Up90 
over the course of the experiment however Dn90 varied over the course of the 
experiment and was significantly increased at 24 hours post pacing (167.9± 16.5 
ms vs 424.7± 60.1 ms P = 0.0162 repeated measures ANOVA). CD90, CD50 and 
CD10 were unchanged throughout the pacing protocol (Figure 4.7). Unpaced, 
stage incubator cells showed no change in Up90 or CD50 (Figure 4.8 A and D). 
Dn90 was significantly increased at 96 hours (462.3 ± 35.1 ms, P=0.0199) and 24 
hours post pacing (330.6 ± 36.9 ms P=0.0168) compared to prepacing values (215 
± 45.73 ms) (Figure 4.8 B). Similar increases were seen in CD90 (0 hours, 99.4 ± 
11.0 ms. 96 hours, 153.9 ± 6.6 ms P=0.008. 24 hours post, 142.7 ± 12.3 ms 
P=0.0235 repeated measures ANOVA) (Figure 4.8 C) and CD10 (0 hours, 378.3 ± 
45.3 ms. 96 hours, 669.3 ± 37.92 ms P=0.0087. 24 hours post, 532.2 ± 46.31 ms 
P=0.002 repeated measures ANOVA) (Figure 4.8 E). Unpaced, full incubator cells 
showed no significant changes in Up90, CD90, CD50 or CD10 over the protocol 
period (Figure 4.9 A, C, D, and E respectively). These cells did however display a 
significant increase in Dn90 at 24 hours post pacing compared to prepacing 
values (333.9 ± 26.8 ms vs 165.1 ± 19.9 ms, P=0.0424 repeated measures ANOVA) 
(Figure 4.9 B). 
Chronic photostimulation caused significant shortening of the sarcomeres when 
compared to unstimulated controls (1.71 ± 0.009m to 1.67 ± 0.012 µm P=0.0193 
unpaired t-test) but had no effect on the sarcomere inhomogeneity or alignment 
(Figure 4.11). 
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Figure 4.5 Cell excitability throughout photostimulation period (96 hours) 
Chronaxie times (i) remained unchanged in paced cells (A) unpaced cells stage incubator cells (B) 
and unpaced full incubator cells (C). Rheobasic power (ii) also remained unchanged in paced 
cells(A) unpaced cells stage incubator cells (B) and unpaced full incubator cells (C) (N = 6 wells). 
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Figure 4.6 Spontaneous cycle length over 96 hours 
Spontaneous cycle length of paced cells was increased at 48 and 96 hours before returning to 
prepaced values after 24 hours of rest. Unpaced cells in both stage and full incubators remained 
unchanged throughout the photostimulation period and following 24 hours of rest (N = 6 wells).       
* P≤0.05, ** P≤0.01 (repeated measures ANOVA) 
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Figure 4.7 Contraction kinetics of paced cells (96 hours) 
Contractility measurements from spontaneous cells. Up90 (A), CD90 (C), CD50 (D) and CD10 (E) 
remained unchanged throughout the photostimulation protocol. Dn90 (B) was significantly 
increased at 24 hours post stimulation (N = 6 wells). * P≤0.05 (repeated measures ANOVA). 
Chapter 4 75 
 
 
Figure 4.8 Contraction kinetics of unpaced cells (stage incubator) 
Contractility measurements from spontaneous cells. Up90 (A) and CD50 (D) showed no significant 
changes. Dn90 (B), CD90 (C) and CD10 (E) showed significant increases at after 96 hours of 
pacing, and after 24 hours of rest (N = 6 wells). * P≤0.05, ** P≤0.01 (repeated measures ANOVA). 
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Figure 4.9 Contraction kinetics of unpaced cells (full incubator) 
Contractility measurements from spontaneous cells. Up90 (A), CD90 (C), CD50 (D) and CD10 (E) 
remained were not significantly different at the protocol endpoint. Dn90 (B) was significantly 
increased after the 24-hour rest period (N = 6 wells). * P≤0.05 (repeated measures ANOVA) 
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Figure 4.10 End point contraction kinetics across all conditions 
Contraction kinetics at 96 hours (black) and 24 hours post pacing (grey) were compared across the 
3 experimental conditions, Paced and unpaced stage incubator cells showed a significantly 
different spontaneous cycle length from unpaced, full incubator cells at 96 hours (A). Up90 (B), 
Dn90 (C), CD90 (D), CD50 (E) and CD10 (F) were not significantly different (N= 6 wells). * P≤0.05, 
** P≤0.01, (1-way ANOVA) 
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Figure 4.11 Cell structure after photostimulation period (96 hours) 
96 hours of photostimulation caused a significant shortening of sarcomere length but caused no 
changes in sarcomere inhomogeneity or alignment (iPSC-CM N = 4 wells, 10 cells/well. Rat 
ventricle N = 3 animals, 10 cells/animal). * P≤0.05, ** P≤0.01, *** P≤0.001 (1-way ANOVA) 
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4.4 Discussion 
4.4.1 Chronic pacing at a single site causes cell death 
Prolonged photostimulation of a single site caused significant damage to the 
cells being stimulated. This indicated a potential toxic effect of the 
photostimulation protocol. This effect was studied in detail in chapter 5.  
4.4.2 48 hours of patterned photostimulation caused changes in 
spontaneous rate 
Changing the photostimulation protocol to include multiple stimulation sites 
within a single well did not prevent cell death after 48 hours. As a result, the 
protocol was further altered to reduce the duty cycle of each well of cells to 
50% by alternating stimulation between 2 adjacent wells. This adaptation 
allowed cells to be paced for 48 hours with no apparent signs of damage. 
Cells paced at 2 Hz for 48 hours showed no changes in structural or functional 
phenotype. Before extending the protocol duration, the work rate of the cells 
was increased by increasing photostimulation frequency to 3 Hz. The increased 
pacing frequency led to an increased spontaneous cycle length after 48 hours 
(Figure 4.4), contrary to previous work showing an adaptation of spontaneous 
frequency to pacing frequency148. Spontaneous activity is one of the major 
markers of immaturity in iPSC-CMs45,50,64 which is likely caused by a lack of Ik1151 
and increased If expression152. The decreased spontaneous rate observed in cells 
paced at 3 Hz could arise from several changes including an increase in Ik1 or 
decrease in If. This could be verified by western blotting, or by examining the 
stability of the resting membrane potential using patch clamping or red-shifted 
voltage sensitive dyes. As the spontaneous rate of iPSC-CMs is so variable (Figure 
2.5), 3 Hz stimulation was used for all subsequent experiments to ensure the 
endogenous rate of the cells was consistently overridden. 
4.4.3 Commercially available iPSC-CMs have a markedly different 
sarcomeric structure from isolated adult cardiomyocytes 
The resting sarcomere length of adult rat ventricular cardiomyocytes is around   
2 µm (Figure 4.11) and around 2.2 µm in human cells153. When kept in culture, 
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Isolated cardiomyocytes undergo dedifferentiation characterised by loss of rod-
like morphology153, decreased sarcomere alignment, and spontaneous electrical 
activity154. The foetal nature of these dedifferentiated cells is remarkably 
similar to that of iPSC-CMs and indicates the structural and electrical 
environment of the heart plays a significant role in increasing and maintaining 
cardiomyocyte maturity. This is consistent with studies attempting to replicate 
the physical environment of the adult heart in immature cell types 
Simulating pressure load using cyclic stretching in engineered heart tissues 
produces cardiomyocytes with an increased sarcomere alignment and rod-like 
morphology52,53. The elastic modulus of the adult heart is approximately double 
that of the neonatal heart155 which in turn is threefold greater than the 
embryonic heart156. Using microfabricated flexible posts to simulate the elastic 
modulus of the developing epicardium, sarcomere length and sarcomere 
alignment has been shown to increase with increasing elastic modulus157. 
Assays replicating the mechanical conditions of the mature heart are low 
throughput and as such commercial stem cell derived cardiomyocytes are 
differentiated in vitro using biochemical factors to increase product yield. As a 
result, commercial cells develop in a non-physiological structural environment 
resulting in a sarcomeric structure that is less organised than adult cells64,153,158.  
The decreased sarcomere length observed in these cells has a significant effect 
on contraction kinetics. At sarcomere lengths shorter than 1.9 µm, unloaded 
shortening velocity (Vo) is dependent on sarcomere length159,160. This dependency 
is due largely to the viscoelastic forces of sarcomeric proteins, namely titin161, 
opposing shortening162. Given a resting length of 1.76 µm (Figure 2.9) and 
assuming a fractional shortening of 5%51, sarcomere length would be reduced to 
1.67 µm at peak contraction. This means that contraction velocity becomes 
progressively slower approaching peak contraction and may account for the 
domed peak seen in contraction traces (Figure 4.12). Of course, there is an 
assumption that the sarcomere length observed in iPSC-CMs is the resting length. 
Due to the spontaneous nature of these cells it is possible that some level of 
contraction occurred during fixation, skewing the results towards a shorter 
length. This could be tested by removing extracellular calcium or the addition of 
an excitation contraction uncoupler (such as blebbistatin) before fixation. 
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Figure 4.12 Contraction and contraction velocity 
Contraction velocity (red line) was estimated by calculating the derivative of a spontaneous 
contraction trace (back line). Contraction velocity begins to decrease before peak contraction is 
reached due to increasing internal resistive forces caused by the reduction in sarcomere length. 
4.4.4 96 Hours of patterned photostimulation at 3 Hz caused 
changes in cell function and structure. 
During the extended pacing protocol there was again a significant increase in 
spontaneous cycle length after 48 hours of 3 Hz photostimulation, however this 
increase was lost after 24 hours of rest. Although not significant, a similar trend 
was present in stage incubator control cells. This trend was not present in cells 
kept in the full incubator. The cycle length of stage incubator cells was 
significantly greater than that of full incubator cells at 96 hours, but not at 24 
hours post (Figure 4.10). This highlights the possibility that the phenotypic 
changes observed might be caused by improper function of the stage incubator. 
Incubator function was tested in chapter 5 where it was determined that 
humidity was being inadequately controlled. 
Low incubator humidity would cause evaporation of cell media and result in an 
increased extracellular solute concentration. This increase would affect the cells 
in several ways. An increase in H+ concentration would cause acidosis and 
adversely affect cell function, however the presence of HEPES buffer in cell 
media should prevent this from occurring.  
Chapter 4 82 
 
Increased concentration of other solutes would result in hypertonicity of the cell 
media. Hypertonic solutions are often used to cause detubulation of muscle cells 
in order to study the effects of t-tubule dysfunction163. Treatment with a 
hypertonic glycerol solution causes an initial decrease in cell volume. Over time, 
cell volume is restored to pre-treatment levels as glycerol enters the cell 
accompanied by an osmotically equivalent volume of water164. Replacement of 
the hypertonic solution with normal solution results in a rapid increase in 
relative cell volume causing osmotic shock and detubulation. Glycerol was 
absent from the cell media used in this project however recovery of cell volume 
could still occur through the movement of other cell permeant solutes. 
Increased extracellular ion concentrations would lead to an increased influx of 
Na+ and Ca2+ during an action potential. Overtime this could increase the 
osmolarity of the cell and cause recovery of cell volume. However, ion flux is 
very slight, and any change of internal concentration and cell volume would be 
minimal. The altered ion distributions would however have significant effects on 
cell electrophysiology. 
The resting membrane potential, as described by the Goldman-Hodgkin-Katz 
equation (Equation 3.1), is determined by the distribution of ions, and the 
permeability of the membrane to said ions. 
Equation 4.1 Goldman-Hodgkin-Katz equation 
Where EM is the resting membrane potential, R is the universal gas constant, T is the absolute 
temperature in kelvin, F is the Faraday constant, P is the relative membrane permeability to ion x 
[x]o is the extracellular concentration of ion x and [x]i is the intracellular concentration of ion x. 
𝐸𝑀 =
𝑅𝑇
𝐹
ln (
𝑃𝑁𝑎+[𝑁𝑎
+]𝑜 + 𝑃𝐾+[𝐾
+]𝑜 + 𝑃𝐶𝑙−[𝐶𝑙
−]𝑖
𝑃𝑁𝑎+[𝑁𝑎+]𝑖 + 𝑃𝐾+[𝐾+]𝑖 + 𝑃𝐶𝑙−[𝐶𝑙−]𝑜
) 
 
An increase in extracellular ion concentrations would lead to a more positive 
resting membrane potential. The increased membrane potential could cause 
slow inactivation of voltage gated sodium channels leading to the increased 
cycle lengths observed after 48 and 96 hours of pacing (Figure 4.6). However, a 
reduction in cell volume due to the hypertonicity of the extracellular solution 
would cause the intercellular concentrations to rise accordingly meaning that 
the resting potential would be minimally affected. Increased [K+]i could lead to 
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increased inward rectifying current, causing stabilisation of the resting 
membrane potential and prolonging the cycle length.  
The transient nature of this change likely due to osmotic shock caused by the 
rapid replacement of cell media. Damage to the cell monolayer would result in 
reduced current sinking, and reduced membrane capacitance decreasing the 
time taken for spontaneous action potential generation, consistent with the 
reduced cycle length observed in these cells (Figure 4.6). This is speculation 
however and the precise cause of the change in cycle length remains unclear. 
Hypertonicity of the extracellular solution might also explain the reduction in 
sarcomere length in paced cells. Reduced cell volume due to hypertonicity has 
been shown to increase Ca2+ content of the sarcoplasmic reticulum (SR) by way 
of an increase in resting [Ca2+]i associated with the decreased cell volume165. 
The immature SR of iPSC-CMs72,166,167 would not remove Ca2+ from the cytosol as 
effectively meaning the resting [Ca2+]i level would remain elevated. Over time, 
the Na+/Ca2+ exchanger would work to oppose this increase, however the 
increased entry of Ca2+ into paced cells via both L-type Ca2+ channels and ChR-2 
could prevent any significant reduction in diastolic [Ca2+]i in these cells. 
Elevated diastolic [Ca2+]i in paced cells would reduce dissociation of Ca2+ from 
contractile myofilaments, resulting in the significantly shorter sarcomeres seen 
in paced cells (Figure 4.11). 
The increase in Dn90 observed after the 24-hour rest period in photostimulated 
cells was mirrored in unpaced, full incubator cells indicating that the increase 
may be a result of the age of the cells rather than a consequence of the pacing 
protocol.  
The significant changes in contraction kinetics observed in control cells kept in 
the stage incubator are likely due to the changes in spontaneous cycle length. 
Due to a stimulation artefact, only recordings from spontaneously active cells 
could be used. As the beating rate was not controlled during contractility 
recordings these results are heavily influenced by the changes in spontaneous 
cycle length. Later experiments utilised a longpass filter to allow simultaneous 
photostimulation and contractility recording.  
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4.4.5 Conclusions 
This chapter has demonstrated that, with some adaptations, photostimulation 
can be used to pace cells for 96 hours. It has however highlighted an inadequacy 
in the stage top incubator as well as a toxic effect of photostimulation. These 
issues must be addressed before directionality can be introduced to the pacing 
protocol and are investigated in detail in chapter 5. 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 5: Investigation and resolution of issues 
arising from chronic pacing trial 
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5.1 Introduction 
Chapter 4 identified 2 factors affecting chronic pacing. 1) single site 
photostimulation resulted in severe cell damage and loss of stimulation-
contraction coupling at the end of the 48-hour pacing period. 2) Multi-site 
photostimulation experiments demonstrated a potential failure of the stage-top 
incubator. Changes in spontaneous cycle length of stage control cells were 
absent in control cells kept in the full-size incubator. Before directionality can 
be introduced to the chronic pacing protocol, the toxic effect of 
photostimulation and the stability of the stage incubator in terms of moisture 
and CO2/pH must first be investigated. 
5.1.1 Incubator function 
Bicarbonate buffer is included in cell media to maintain the pH of the solution at 
physiological levels. Hydrogen concentration is maintained through the following 
reaction: 
Equation 5.1 Bicarbonate equilibrium 
Bicarbonate equilibrium reaction by which pH can be maintained with constant perfusion of CO2 
𝐶𝑂2 + 𝐻2𝑂 ⇌  𝐻2𝐶𝑂3  ⇌ 𝐻𝐶𝑂3
−  + 𝐻+ 
For pH maintenance to work effectively using a bicarbonate buffer, adequate 
CO2 partial pressure must be maintained or the solution will become basic. As 
seen in control cells in the previous chapter, there was a tendency for the 
spontaneous cycle length to vary over time. Although not significant this trend 
could indicate possible cellular damage in un-photostimulated cells, which could 
be due to improper incubator function. The most likely parameters that could 
result in cellular damage is inadequate CO2 levels leading to an increase in pH, 
or inadequate humidification leading to evaporation and a subsequent increase 
in extracellular ionic concentrations. 
To test incubator function, two fluorescent indicators were employed, 2',7'-bis-
(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF), and calcein. BCECF is a 
fluorescent pH indicator sensitive to pH changes around cytoplasmic 
norms168(Figure 5.1). Calcein in its membrane permeable AM form is often used 
as a marker of cell viability. In its free acid form, calcein is useful as a marker of 
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fluid volume, as any change in volume will alter the concentration, and 
therefore, the level of fluorescence.  
 
Figure 5.1 Structure and spectra of BCECF 
(A) Structure of bis(carboxyethyl)carboxyfluorescein (BCECF). (B) Excitation and emission spectra 
of 70 nM BCECF at the indicated pHs. The calibration solution contained 130 mM KCI, 10 mM 
NaCI, I mM MgSO+, and 10 mM Na MOPS. pH was altered by addition of IM HCI. Excitation 
spectra recorded at 530 nM in "energy" mode. Emission spectra recorded with excitation at 500 
nm, in "ratio" mode. Hill plots of excitation and emission signal at 500 and 530 nm, respectively, 
give apparent pK~s of 6.96 and 6.98. Figure obtained from Rink et al 1982168 
5.1.2 Electrical stimulation causes tissue damage. 
There is extensive evidence that implanted pacing electrodes cause damage and 
fibrosis to the surrounding myocardium169-172.There are 2 main theories as to the 
underlying cause of stimulation induced tissue damage. The first of these 
proposed mechanisms is the mass action theory, where hyperactivity of the 
stimulated tissue causes changes in the local electrophysiological 
environment173. The second proposed mechanism is the generation of toxic 
products at the surface of the electrode itself. Faradaic reactions in the 
presence of oxygen causes the production of reactive oxygen 
species(ROS)149.These free radicals can cause protein oxidisation and alteration 
of amino acids174,175, as well as oxidising DNA structures176.  
5.1.3 Phototoxicity 
Phototoxicity describes the ability of a chemical substance to produce toxic 
effects upon exposure to light. This ability has been used previously in a 
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technique known as photochemotherapy. This involves the use of a chemical 
photosensitiser coupled with light therapy to target cancerous cells177. In a less 
clinical setting, phototoxicity occurs during imaging experiments with optical 
dyes, during which interaction between light and the fluorophore causes the 
generation of reactive oxygen species, resulting in loss of plasma membrane 
integrity178. In this case, the optical dye acts as the photosensitising agent.  
There is evidence to suggest that phototoxicity can occur without the addition of 
a photosensitiser. Exposure to high intensity blue light (400-500 nm) has been 
shown to have an anti-microbial effect. It is likely that the toxic effect of 
illumination is photochemical in nature as illumination had negligible effects on 
temperature or composition of cell media179. It has been shown that in some 
bacterial species, phototoxicity is oxygen dependent180, suggesting that the 
production of ROS may play a role. This is reinforced by work showing that 
presence of light sensitive proteins such as phycobiliproteins in certain 
microorganisms can result in the production of ROS when exposed to oxygen and 
light181. 
Of perhaps greater relevance to this project is work showing the phototoxic 
effect of a channelrhodopsin-2 variant (D156A) in human melanoma cells182. 
Three days of exposure to pulsed illumination (470 nm, 6.0 mW/mm2, 1s on 10s 
off) significantly increased the percentage of apoptotic cells when compared to 
illuminated cells with negative expression and non-illuminated cells with 
positive expression. The increased levels of apoptosis in the experimental group 
were attributed to an increase in cytosolic Ca2+ levels, which was corroborated 
increased apoptotic levels in cells treated with calcium ionophore. Interestingly 
there was a small but significant increase in apoptosis in illuminated control 
cells compared to non-illuminated transfected cells. These results indicate that 
the illumination pattern, the light intensity and the Ca2+ entry via 
channelrhodopsin all contribute to the final cytotoxic effect. 
5.1.4 Aims 
The aims of this chapter were to: 
1) Identify faults in incubator function and attempt to correct issues 
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2) Quantify cellular damage caused by chronic optogenetic stimulation of a 
single site.  
3) Determine if damage arose due to photocurrent injection or as a direct 
result of prolonged exposure to 470 nm illumination. 
5.2 Methods 
5.2.1 pH measurements 
To ensure pH changes could be detected, BCECF fluorescence was recorded at 
pHs of 6.9, 7.2, 7.4, 7.6 and 7.9. 0.5 µM BCECF was added to cell media in a 
glass bottomed 96 well plate and fluorescence was recorded (Excitation: 470 
nm. Emission: 535-585 nm) periodically over 48 hours.  
5.2.2 Evaporation measurements 
A 96 well plate was filled with water and weighed before placing in the stage 
incubator for 48 hours. The plate was reweighed every 24 hours. 
2 µM Calcein was used as a marker of relative fluid volume. Fluorescence was 
measured (Excitation: 470 nm. Emission: 535-585 nm) periodically over 48 hours. 
Calcein fluorescence was calibrated by measuring fluorescence at concentrations 
of 0.1, 0.2, 0.5, 1, 2 and 5 µM. 
5.2.3 Cell Plating and viral transfection 
Cells were plated under standard plating conditions. 12 wells were transfected 
at an MOI of 2500 and 6 wells received no virus. 
5.2.4 Photostimulation 
6 wells of transfected cells and 6 wells of untransfected cells underwent 
extended stimulation. 6 wells of transfected cells were left unstimulated as 
controls (Figure 5.2). A single cell area per well was exposed to 3 Hz 5 ms pulses 
of 470 nm light with an intensity of 1.36 mW/mm2 for 48 hours. Cell contraction 
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was recorded every 10 minutes using open source automation software (Perfect 
Automation) in conjunction with standard contraction protocols. 
 
 
Figure 5.2 Mortality protocol timeline 
Transfected cells were either photostimulated at 3 Hz (Blue) or left un-stimulated (Yellow). 
Untransfected cells were also photostimulated at 3 Hz (Blue). Cells were recorded every ten 
minutes for up to 48 hours. 
5.2.5 Image analysis 
5.2.5.1 Functional parameters 
Contraction amplitude, cycle length, and duration at 50% contraction was 
acquired using the ImageJ macro previously described. The average percentage 
change per hour was plotted up to 24 hours (Figure 5.8)  
5.2.5.2 Cell area 
In ImageJ a single image from hourly recordings was used to determine the total 
area occupied by cells. The background was subtracted from each image using a 
rolling ball radius of 2.0. The image was then thresholded and converted to a 
binary image. The total area of the particles within the binary image was used as 
a measure of the total cell area. The cell area over 48 hours was plotted and the 
gradient used to compare change in cell area between conditions (Figure 5.8). 
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5.2.6 Statistics 
Conditions were compared using a one-way ANOVA or 2-way ANOVA where 
appropriate. All data are displayed as mean ± SEM. A p value of 0.05 or less was 
considered significant. 
5.3 Results 
5.3.1 BCECF fluorescence increased despite the presence of       
20 mM HEPES 
 
Figure 5.3 BCECF fluorescence over 48 hours 
A) BCECF fluorescence response to altered pH. B) BCECF fluorescence increased with time. This 
increase was unaffected by the presence of 20 mM HEPES buffer (N = 3 wells). 
Over the course of 48 hours there was a steady increase in BCECF fluorescence 
to 112% above baseline levels, and 128% in the presence of 20 mM HEPES (Figure 
1.3).  
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5.3.2 Increase in BCECF fluorescence likely caused by volume 
loss 
 
Figure 5.4 Calibration of calcein fluorescence 
Calcein fluorescence relative to working concentration of 2 µM. Fluorescence increased linearly 
with increasing calcein concentration. Y = 39.43X + 17.77 (N = 3 wells). 
After 48 hours in the stage incubator there was a 13.6% loss of volume by 
weight. This was accompanied by a 55% increase in BCECF fluorescence and a 
160% increase in calcein fluorescence (Figure 5.5 A). Using the calcein 
calibration (Figure 5.4) calcein concentration was estimated to rise from 2 µM to 
6.14 µM, meaning the volume in the well had decreased from 200 µl to 65 µl. 
This would result in BCECF concentration being increased to 1.53 µM. 
Subsequently, the humidity of the stage incubator was increased from ~70% to 
~90-95% by increasing the temperature of the bubble humidifier. 48 hours at this 
higher humidity level resulted on only a 5.5% loss of volume by weight which was 
accompanied by an increase in BCECF fluorescence of 10% and calcein 
fluorescence of 5% (Figure 5.5 B), indicating an increase in calcein concentration 
to 2.21 µM and a reduction in volume to 180 µl. 
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Figure 5.5 Fluorescence at high and low humidity 
Fluorescence of both pH sensitive(BCECF) and insensitive(Calcein) markers was increased after 
48 hours at original humidity setting (A). With the incubator humidity increased there was a 
negligible increase in fluorescence of both markers (B) (N = 6 wells). 
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5.3.3 The contraction profile of transfected, photostimulated cells 
alters drastically over 24 hours. 
All cell areas that were both transfected and photostimulated lost 1:1 
contraction coupling before 24 hours (average time for loss of coupling was 2.19 
± 1.26 hours) (Figure 5.6). Only 1 out of 6 of these areas showed any 
spontaneous activity at 24 hours (Figure 5.7). 
 
 
Figure 5.6 Contraction before and after 
Example contraction traces for all three experimental conditions at 0 (i) and 24 hours (ii). The 
contraction profile remained largely unchanged in transfected unstimulated cells (A) and 
untransfected photostimulated cells (C). Transfected photostimulated cells (B) showed marked 
changes after 24 hours with total loss of stimulation-contraction coupling along with a significant 
increase in contraction duration. 
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Figure 5.7 Contraction cycle length over 24 hours 
Cycle lengths for the three experimental conditions over 24 hours. Cycle lengths for transfected, 
unstimulated cells (A, N = 5 areas), and untransfected, photostimulated (B, N = 5 areas) remained 
largely unchanged throughout the duration of the experiment. (Figure 5.9) Transfected, 
photostimulated cells (C, N = 6 areas) lost 1:1 coupling within 2.19 ± 1.26 hours (D) and only 1 of 6 
cell areas still showed contraction at 24 hours. 
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Figure 5.8 Example contraction changes over time 
A) % Change in contraction amplitude, B) CD50 and C) cell area was plotted against time. As 
changes in amplitude and cell area are relative, the rate of change was used to identify significant 
differences between experimental conditions. 
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5.3.4 Rate of change was unaffected by transfection or 
photostimulation 
There were no significant differences in rate of change of spontaneous 
amplitude, area, cycle length or CD50 between the 3 experimental groups. 
(Figure 5.9). 
 
Figure 5.9 Contraction gradients post protocol 
Average % change/hour in A) Amplitude, B) cell area, C) cycle duration at 50% contraction and D) 
cycle length. There were no significant changes in amplitude or area across all three conditions 
(Transfected, photostimulated N = 6 areas, transfected, unstimulated N = 5 areas, untransfected 
stimulated N = 5 areas) The gradient of CD50 and cycle length % change over time was 
significantly more positive in transfected photostimulated cells. 
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5.3.5 The presence of channelrhodopsin alters cell contractility 
Untransfected cells showed no change in amplitude, cell area, CD50 or cycle 
length at the end of the experimental period (Figure 5.10). Transfected, 
photostimulated cells showed a significant decrease in cell area at the end of 
the 48-hour pacing period (100% vs 55.99 ± 13.45%, p = 0.0174 2-way anova) as 
well as a significant increase in CD50 (151.73 ± 10.17 ms vs 425.78 ± 62.11 ms, P 
= 0.0002 2-way anova) and cycle length (368.71 ± 32.54 ms vs 985.17 ± 92.33 ms, 
P = 0.0006). Transfected, unstimulated cells also showed small but significant 
increases in CD50 (382.81 ± 54.67 ms vs 538.67 ± 62.75 ms, p = 0.0331) and cycle 
length (1963.45 ± 828.29 ms vs 2487.80 ± 889.83 ms, p = 0.0051 2-way anova) 
(Figure 5.10). 
 
Figure 5.10 Cell function and coverage pre and post protocol 
Initial values for A) amplitude, B) area, C) CD50 and D) cycle length compared to terminal values. 
There were no significant changes in contraction amplitude in any of the experimental groups. Cell 
area in the transfected, photostimulated group was significantly reduced after 48 hours of 
photostimulation. After 24 hours, CD50 was significantly increased in both the transfected, 
photostimulated group, and the transfected unstimulated group. Cycle length was also significantly 
altered in these groups (Transfected, photostimulated N = 6 areas, transfected, unstimulated N = 5 
areas, untransfected stimulated N = 5 areas). 
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5.4 Discussion 
5.4.1 BCECF fluorescence increased despite the presence of      
20 mM HEPES 
BCECF fluorescence increases with increasing pH (Figure 5.1, Figure 5.3A). 
Insufficient partial pressure of CO2 would cause the bicarbonate equilibrium to 
shift towards the left (Equation 5.1), removing H+ from solution and increasing 
the pH of the solution. The addition of 20 mM HEPES did not prevent affect the 
increase of BCECF fluorescence (Figure 5.3B). Given that the buffering power of 
HEPES is not dependent on CO2 partial pressure, 20 mM should have been more 
than adequate to prevent a significant rise in pH, meaning the rise in 
fluorescence was not due to insufficient partial pressure of CO2. The increased 
fluorescence was therefore most likely caused by an increase in concentration 
caused by evaporation of media due to inadequate humidity in the incubator 
chamber. 
5.4.2 Increase in BCECF fluorescence likely caused by volume 
loss 
The inadequate humidity of the incubator was confirmed by a significant loss of 
fluid from the test plate after 48 hours along with an increase in calcein 
fluorescence. The change in calcein fluorescence was drastically reduced upon 
increasing incubator humidity indicating reduced fluid loss. Improving incubator 
humidity also reduced the change in BCECF fluorescence, confirming that the 
increase observed previously was not due to improper CO2 partial pressure. 
The increased calcein fluorescence observed at low humidity was far greater 
than the increase in BCECF fluorescence. As BCECF is pH sensitive, it could be 
hypothesised that a reduction in pH led to reduced fluorescence, opposing the 
increase due to concentration. However, evaporation would cause an increased 
bicarbonate concentration causing pH to increase meaning this hypothesis was 
unlikely. As calcein is Ca2+ sensitive, it is more likely that increased Ca2+ 
concentration combined with the increase in indicator concentration led to 
disparity between calcein and BCECF fluorescence. Inconsistencies between 
weight measurements and volume calculations are likely due to evaporated 
solution condensing elsewhere in the plate, thus removing volume from the well 
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and influencing calcein fluorescence, but still contributing to the overall weight 
of the dish. 
A reduction in extracellular volume would explain the changes in cycle length 
seen previously (Figure 4.6). Increased concentration of extracellular ions would 
cause an increase in resting membrane potential and a reduction in cell volume 
due to increased osmotic pressure (detailed interpretation in chapter 4). 
Restoring incubator humidity abolished the changes in spontaneous cycle-length 
in control cells in subsequent experiments (chapter 6). 
5.4.3 The contraction profile of transfected, photostimulated cells 
alters drastically over 24 hours. 
In adult cardiomyocytes, increased contraction frequency leads to increased 
force of contraction. This positive force-frequency relationship occurs as a result 
of increased Ca2+ influx via L-type calcium channels and a decreased diastolic 
period resulting in decreased Ca2+ efflux via the Na2+/Ca2+ exchanger. In adult 
cells, the excess Ca2+ is removed to the sarcoplasmic reticulum (SR) by 
sarco/endoplasmic reticulum Ca2+-ATPase (SERCA). This results in increased SR 
content, an increased intracellular Ca2+ transient, and an increase in contractile 
force.  
Stem cell derived cardiomyocytes have been shown to have reduced SR 
capacity72,166 where the removal of excess cytosolic Ca2+ to the SR is diminished, 
leading to a negative force-frequency relationship72,74 similar to that seen in the 
failing human heart183. A negative force frequency relationship occurs when 
increased Ca2+ entry via the L-type Ca2+ channel cannot by removed by the 
impaired SR causing an increase in diastolic Ca2+. This increase leads to reduced 
relaxation and therefore a reduction in contractile force. Insufficient Ca2+ 
removal during chronic pacing would cause an increased CD50 such as that 
observed in transfected, photostimulated cells (Figure 5.6 and Figure 5.10). This 
in turn would cause an increased refractory period and result in the loss of 
coupling observed in these cells (Figure 5.6 and Figure 5.7).  
Loss of coupling may also have occurred due to a diminished photocurrent 
amplitude. As the ChR-2 current consists partly of Ca2+ flux, increased 
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intracellular Ca2+ levels would decrease the Ca2+ gradient resulting in a 
diminished inward current. This could lead to photostimulation being insufficient 
to depolarise the cell to the threshold required for action potential generation. 
A prolonged increase in cytosolic calcium would also explain the cell death 
observed in transfected, photostimulated cells. Perny et al (2016) proposed an 
apoptotic pathway in which increased cytosolic calcium leads to release of 
cytochrome c from the mitochondria. This in turn leads to formation of the 
apoptosome leading to terminal DNA fragmentation and apoptosis182. 
In future studies this hypothesis should be tested using red-shifted Ca2+ and 
voltage sensors compatible with ChR-2 based optogenetics184. 
5.4.4 The presence of channelrhodopsin alters cell contractility 
Channelrhodpsin-2 (H134R) has a constant steady state current in the presence 
of 470 nm light109. As shown previously (Figure 2.6) ChR-2 also has a broad action 
spectrum at the short end of the visible spectrum. As such, it is likely that 
brightfield illumination caused constant photocurrent injection at a level below 
the threshold for action potential generation. The presence of this continuous 
current likely causes prolongation of the plateau phase of the action potential. 
This prolongation would result in the prolonged contraction duration observed in 
transfected, unstimulated cells which in turn would result in the decreased 
contraction frequency also seen in these cells. As ChR-2 current is comprised of 
influx of several cations, prolonged channel opening is likely to prevent recovery 
of the resting membrane potential and cause slow inactivation of voltage gated 
sodium channels. This inactivation, coupled with the prolonged CD50, is likely 
the cause of the increased cycle length (Figure 5.10). Again, these hypotheses 
should be tested in future using appropriate voltage sensors. 
As there were no significant changes in the untransfected, photostimulated 
cells, secondary effects such as increased temperature, and the generation of 
ROS by the stimulus light can be ruled out. 
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5.4.5 Conclusions 
These results indicate that prolonged optogenetic stimulation of a single site of 
iPSC-CMs causes cell damage, future chronic pacing experiments should 
therefore utilise a multi-site protocol as shown in chapter 4. With incubator 
function restored, and a greater understanding of cell mortality, directionality 
was added to the chronic pacing protocol in chapter 6.
 
 
 
 
 
 
 
 
 
 
 Chapter 6: Investigation into the effect of 
directional pacing on iPSC-CMs 
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6.1 Introduction 
Chapter 5 investigated the issues plaguing chronic photostimulation. With these 
factors resolved, directionality could be introduced into the chronic pacing 
protocol. 
6.1.1 Directional electrical activity 
As mentioned in chapter 1, the very first heart beats during development arise 
from spontaneous activity within the immature cardiomyocytes before being 
overridden by the sino-atrial node. Directional activation is generated at the top 
(cranial) end of the heart tube, the wave of activation propagates to the dorsal 
end on each beat. This wave of electrical activity causes peristaltic motion with 
contraction direction being perpendicular to the direction of electrical 
activation. Previous studies attempting to increase the maturity of stem cell 
derived cardiomyocytes by replicating the physical environment of the 
developing or developed heart have been quite successful52,53,157,185. As such, it 
was hypothesised that altering the multi-site stimulation protocol to replicate 
the directional pattern of electrical activity seen during development could 
increase the maturity of iPSC-CMs. 
6.1.2 Aims 
This chapter aimed to determine: 
1) If the improvements made to the stage incubator would prevent adverse 
changes to cell function. 
2) If directional photostimulation could cause changes in iPSC-CM structure 
and function. 
6.2 Methods 
6.2.1 Cell Plating 
Stem cell derived cardiomyocytes (Axiogenesis) were seeded onto fibronectin 
(1:100 PBS) coated inserts, within Mattek 35 mm glass bottomed petri dishes at a 
density of 25,000 cells per well. 
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6.2.2 Viral Transfection 
Cells were incubated overnight with an adeno-associated virus containing ChR2 
(Addgene# 20938M obtained from Vector Biolabs, Pennsylvania) at an MOI of 
2500. Cells were then allowed to rest for 5 days to allow full expression of the 
ChR2 protein. 
6.2.3 Contractility Recordings 
Cell contractions were recorded using a Hamamatsu orca flash 4.0 camera 
attached to an Olympus IX71 Microscope at 40x magnification. Contractility 
recordings were analysed using in-house software developed by Dr Francis 
Burton.  
6.2.4 Chronaxie determination 
Responsive cells were excited at 3 Hz with a 470 nm opto-led and the threshold 
for response measured at 0.2, 0.3, 0.5, 0.7, 2,3,5,7,10,20,30 and 40 ms Pulse 
widths. These values were then fitted with an exponential and the chronaxie 
was taken as the pulse width for twice the rheobasic current.  
6.2.5 Sarcomere analysis 
6.2.5.1 Immunohistochemistry 
Fixed cells were permeabilised using 0.2% triton in 1% bovine serum albumin 
(BSA) phosphate buffered saline (PBS) before being blocked with 10% goat serum 
(GS) 1%BSA PBS for 1 hour. The cells were then stained with mouse anti-α-actinin 
(1:500 3%GS 1%BSA PBS) overnight at 4°C. Cells were then washed and stained 
with goat anti-mouse IgG alexafluor 647 antibodies (1:200 1% BSA PBS) for 1.5 
hours at room temperature. 
6.2.5.2 Sarcomere Imaging. 
Z-stacks of cells with well-defined sarcomeres were obtained using an Olympus 
IX83 confocal microscope at 40x or 60x magnification. 
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6.2.5.3 Image analysis 
Maximum intensity projections were obtained in open-source image analysis 
software FIJI. These images were then analysed as described in chapter 2. 
6.2.6 96-hour directional pacing 
In-house software was used to move the area of stimulation between 6 central 
sites per well. These sites were positioned in such a way that, although they 
would arise from either side of the measurement area, action potentials 
propagating from each site would share a similar directional axis (Figure 6.1). 
Sites were stimulated at 3 Hz with a 2 ms pulse width for 100 seconds. 
Stimulation was alternated between 2 adjacent inserts to allow concurrent 
stimulation with a duty cycle of 50%. Contractility recordings and strength 
duration curves were taken from central sites that did not undergo direct 
photostimulation. Measurements were made before pacing, after 48 and 96 
hours of pacing, as well as after a 24-hour post-pacing rest period (Figure 6.1). 
Cell media was replaced every 48 hours and cells were fixed post-experiment 
using 2% paraformaldehyde (PFA).  
6.3 Results 
6.3.1 96 hours of directional stimulation caused minor changes to 
cell contractility 
Patterned stimulation caused no changes to the spontaneous cycle length of 
paced cells (Figure 6.2 A, Figure 6.4). Although there was no change during the 
stimulation protocol, there was a significant decrease in the contraction 
upstroke time of cells paced at 3 Hz after the 24-hour rest period (72.03 ms vs 
48.85 ms P=0.023 one-way ANOVA) (Figure 6.2 B). There was however, no 
change in the contraction downstroke time (Figure 6.2 C). 
There was a temporary decrease in spontaneous cycle length in control cells 
(1272 ± 230 ms vs 727 ± 99 ms, P = 0.0255) however there were no significant 
changes in other contractility parameters (Figure 6.3) 
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Figure 6.1 Directional pacing protocol 
Visual representation of directional photostimulation pattern. Each site was photostimulated for 100 
seconds before stimulation was moved to the corresponding site in the alternate well. This 
stimulation pattern was maintained for 96 hours. 
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Figure 6.2 Contractility in paced cells during pacing protocol 
96 hours of directional pacing caused no change in the spontaneous cycle length of the paced cells 
(A) or the relaxation phase of cells paced at 3 Hz (C). 24 hours after the pacing period however, 
there was a significant decrease in the upstroke time of the contraction phase of cells paced at 3 
Hz (B) (72.03 ms decreased to 48.85 ms P=0.023 one-way ANOVA). There were no significant 
changes in (D) CD90, (E) CD50 or (F) CD10 (N = 6 wells). 
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Figure 6.3 Contractility in control cells during pacing protocol 
There was a significant decrease in spontaneous cycle length (A) at 96 hours which was lost at 24 
hours post protocol. There were no significant changes in B) Up90, C) Dn90, D) CD90, E) CD50 or 
F) CD10 (N = 6 wells). 
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Figure 6.4 Spontaneous cycle length in control and paced cells 
The spontaneous cycle length of paced cells did not differ significantly from that of control cells at 
any point during the photostimulation period (N = 6 wells). 
6.3.2 96 hours of directional stimulation did not alter cell 
excitability 
There were no significant changes in the chronaxie times or rheobasic stimuli of 
paced cells (Figure 6.5) 
6.3.3 96 hours of directional stimulation did not alter cell 
structure 
There were no significant changes in sarcomere length (Figure 6.6 A), 
inhomogeneity (Figure 6.6 B), or alignment (Figure 6.6 C) following 96 hours of 
patterned stimulation. 
 
Figure 6.5 Cell excitability before and after protocol 
There was no significant effect of patterned stimulation on markers of cell excitability Chronaxie (A) 
and Rheobasic stimulus (B) (N = 6 wells). 
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Figure 6.6 Cell structure post-protocol 
Chronic directional stimulation caused no changes in sarcomere length, sarcomere inhomogeneity, 
or sarcomere alignment (iPSC-CM N= 6 wells, 10 cells/well. Rat ventricle N = 3 animals, 10 cells/ 
animal) 
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Table 6.1 Cell phenotype pre/post-protocol 
Mean values for all directional pacing parameters in control/pre-treated cells and treated cells.  
 Control Treated 
Spontaneous cycle length 
(ms) 
946.00 ± 201.70 1562.00 ± 439.60 
Up90 
(ms) 
72.03 ± 6.73 48.85 ± 2.78 * 
Dn90 
(ms) 
102.80 ± 7.21 145.30 ± 19.78 
CD90 
(ms) 
68.10 ± 4.78 70.49 ± 3.31 
CD50 
(ms) 
165.90 ± 8.31 183.50 ± 14.4 
CD10 
(ms) 
243.50 ± 4.56 264.60 ± 23.31 
Chronaxie 
(ms) 
4.79 ± 1.18 7.69 ± 2.87 
Rheobase 
(mWmm-2) 
0.62 ± 0.26 0.28 ± 0.08 
Sarcomere length 
(µm) 
1.77 ± 0.04 1.72 ± 0.02 
Sarcomere inhomogeneity 
(µm) 
0.45 ± 0.03 0.46 ± 0.04 
Sarcomere dispersion 
(°) 
20.27 ± 1.47 18.21 ± 1.33 
N 6 wells 6 wells 
 
6.4 Discussion 
6.4.1 96 hours of directional stimulation caused minor changes to 
cell contractility 
The significant changes in spontaneous cycle length observed during previous, 
multi-site experiments were absent in the directionally paced cells. This is 
consistent with the hypothesis that the changes in spontaneous cycle length seen 
previously were due to improper incubator function. Restoring the humidity of 
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the stage incubator resulted in a vastly decreased fluid loss (chapter 5) meaning 
the cells were no longer subjected to altered ion concentrations, preventing the 
increase in spontaneous rate. 
Previously, contraction recordings in control cells in showed significant changes 
in contraction kinetics throughout the multi-site pacing period (Figure 4.8). Due 
to an artefact caused by photostimulation, contraction kinetics were measured 
on spontaneously active cells. As a result, kinetics were greatly affected by 
changes in spontaneous cycle length. With the addition of a longpass emission 
filter between the camera and cells, contraction recording and photostimulation 
could be performed simultaneously. With a consistent beating rate, the 
contraction kinetics of control cells did not change significantly throughout the 
directional pacing period (Figure 6.3).  
The significant decrease in Up90 observed in directionally paced cells can 
therefore be attributed to the pacing protocol rather than a secondary effect of 
fluid loss and spontaneous rate. The increased speed of contraction likely 
represents faster Ca2+ release from the sarcoplasmic reticulum, consistent with a 
more mature Ca2+ handling system166,186,187. Alternatively, this could represent 
changes in internal resistive forces due to altered expression of sarcomeric 
proteins. 
These findings should be verified using appropriate optical sensors, however they 
indicate that directional electrical activity can increase the functional maturity 
of iPSC-CMs. 
6.4.2 96 hours of directional stimulation did not alter cell 
excitability 
The adult cardiomyocyte has a significantly larger cell capacitance, due to the 
presence of T-tubules, along with a more negative resting membrane potential, 
and a greater upstroke velocity than iPSC-CMs64,82. If directional pacing caused 
changes in these functional parameters, they would be reflected in the strength-
duration curve.  
The slower upstroke velocity observed in iPSC-CMs can be attributed to lower 
expression of voltage gated sodium channels. As blockade of voltage gated 
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sodium channels shifts the strength-duration curve up and to the right134,135,137, 
an increase in sodium channel density associated with maturation would be 
expected to produce a strength duration curve with a reduced chronaxie and 
rheobase. A lack of change in the strength duration curve (Figure 6.5) indicates 
that directional pacing did not induce significant changes in expression or 
activation of voltage gated ion channels. 
The more negative membrane potential associated with maturity would require 
a larger stimulus current in order to reach threshold and would be reflected by 
an increased rheobase188,189. However, as ChR-2 rheobase is determined by the 
intensity of illumination and ChR-2 current amplitude displays strong inward 
rectification108,109, membrane hyperpolarisation would be accompanied by an 
increased photocurrent amplitude, preventing an increase in rheobase and 
obscuring the effect of membrane potential. An increase in rheobase due to 
increased cell capacitance would not be affected by the inward rectification of 
ChR-2. 
Taken alongside the absence of significant changes to spontaneous cycle-length 
(Figure 6.2), the absence of any changes to rheobase (Figure 6.5) indicates that 
directional pacing has not significantly altered the excitability of iPSC-CMs  
6.4.3 96 hours of directional stimulation did not alter cell 
structure 
The lack of changes to sarcomeric structure indicates that directional electrical 
activity alone is insufficient to significantly alter iPSC-CM structure. This is at 
odds with several studies that have shown that electrical stimulation can 
influence sarcomeric structure48,148. The most likely explanation for this 
inconsistency the longer time courses used in these studies (5 days – 4 weeks). 
Given the 50% duty cycle used in this project, each well is stimulated for only 48 
out of the 96-hour pacing protocol. Increasing the duration of the stimulation 
protocol may increase the effect of directional stimulation on cell structure. 
Additionally, replicating the directional contraction axis of the developing heart 
in addition to the directional electrical axis may promote structural changes in 
these cells.  
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6.4.4 Conclusions 
Directional pacing can modestly improve contractile function in iPSC-CMs, but 
could be improved by prolonging the stimulation protocol and supplementing 
with additional structural factors  
 
 
 
 
 
 
 
 
 
 
 
 Chapter 7: General discussion 
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7.1 Background 
The aim of this project was to determine if the structure and function of 
commercially available iPSC-CMs could be altered by replicating the electrical 
activity of the developing heart. 
As stated in chapter 1, the developing heart consists of a muscularised tube with 
peristaltic contractions9. Because of their value as a diagnostic tool92,97 this 
project aimed to improve the maturity of iPSC-CMs using optogenetic stimulation 
to mimic the directional electrical activity observed during development. Cell 
contractility, spontaneous activity and sarcomere structure were used as 
indicators of cell maturity as these parameters best represent the contrast 
between mature and immature cells50,63,64. 
7.2 Major findings 
7.2.1 Distribution of contractility parameters 
Using baseline spontaneous recordings gathered throughout the course of this 
project several histograms were generated showing the distribution of the 
contractility parameters (Figure 2.5). The spontaneous cycle length of cells did 
not conform to a gaussian distribution with the majority of cells having a beating 
rate between 0.5 and 3 Hz. As contraction kinetics are heavily influenced by 
contraction frequency, the kinetics of spontaneously beating cells were also non-
normally distributed. 
7.2.2 Success of viral transfer 
Viral transfection (at MOIs of 2,500 and above) was successful and allowed for 
full control of cell beating rate at 5 days post-transfection. Although high, 
transfection with an MOI of 2,500 showed no negative effects such as loss of cell 
viability or death in the week following transfection. 
7.2.3 Comparison of optogenetic and field stimulation 
Published literature has shown the chronaxie of ChR-2 based optogenetic 
stimulation is greater than that of cathodal stimulation140,142-146. Chronaxie is a 
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useful metric for comparing the excitability of various tissues, however it can be 
heavily influenced by stimulus waveform amongst other factors. The inverse 
strength-duration relationship (𝐼𝑡 =
1
𝑡⁄ ) assumes a constant current pulse. For 
non-constant current pulses (such as a capacitor discharge) chronaxie is 
significantly greater190. This is particularly relevant to optical chronaxie 
measurements as ChR-2 does not produce a constant photocurrent. An initial 
peak decays exponentially to a steady state with a decay constant of around 23 
ms191 or 7 ms for the gain of function mutant (H134R)109, meaning current 
injection at shorter pulse-widths is similar to that of a capacitor discharge. 
Confounding this is the strong inward rectification of ChR-2109,192 resulting in a 
reduced current amplitude as the membrane potential reaches positive values. 
These waveform differences are likely the cause of the significant differences 
between optogenetic and electrical stimulation reported in literature. 
In this project, ChR-2 and electric field stimulation were not significantly 
different. This inconsistency with published literature could be a consequence of 
the spontaneous activity present in these cells. The threshold currents recorded 
were not the threshold for action potential generation, but the current required 
to completely override the spontaneous rate of the cells. It is likely that ChR-2 
photocurrent works in concert with other depolarising currents, decreasing the 
photocurrent required to reach threshold and altering the position of the 
strength duration curve. 
7.2.4 Issues with prolonged photostimulation dictated protocol 
for long term photostimulation experiments 
Initial experiments suggested a significant toxic effect of prolonged 
photostimulation. Loss of photostimulation:contraction coupling was observed 
after only a few hours and cell death occurred within the photostimulation area 
after 24 hours. A thorough investigation revealed that toxicity was not caused by 
470 nm illumination, but rather overactivity of paced cells. The proposed 
mechanism posits that increased Ca2+ entry via the L-type Ca2+ channel 
overwhelms the immature Ca2+ handling apparatus of the iPSC-CM leading to an 
increase in diastolic Ca2+ levels. This would cause an increased contraction 
duration and an increase in resting membrane potential resulting the observed 
loss of coupling via slow inactivation of voltage gated sodium channels. The 
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observed reduction in viable cell area can be attributed to the increased 
diastolic Ca2+ levels causing activation of apoptotic pathways182.  
Although not as large, transfected unstimulated cells showed changes in 
contractility similar to that seen in transfected, stimulated cells after 24 hours. 
ChR-2 is activated by light at the short end of the visible spectrum (Figure 2.6) 
meaning the brightfield illumination used to facilitate repeated recordings would 
cause channel opening. Although clearly below the threshold for action potential 
generation, continuous Ca2+ entry would result in an increased contraction 
duration and spontaneous cycle length. 
The use of a multi-site pacing protocol limits the exposure of each 
photostimulation site. Using this method, cells were successfully paced at 3 Hz 
for 96 hours. This method does however have some limitations. Currently the 
protocol uses 6 sites in each well, alternating between wells, leading to a duty 
cycle of 50% i.e. each well is only being paced 50% of the time. Several attempts 
were made to increase the duty cycle to 100% by only moving the stimulation 
between 6 sites within the same well. This however also resulted in loss of 
coupling and cell death at the stimulation sites. 
Initial pacing experiments also highlighted a malfunction within the stage-top 
incubator. Changes in spontaneous cycle length in multi-site stimulated cells 
were mimicked in control cells (Chapter 4). Further experiments revealed that 
the humidity was not being adequately controlled (Figure 5.5). Although this 
inadequacy was corrected, a significant but temporary change in spontaneous 
cycle length was detected in control cells within the directional pacing study 
(Figure 6.3). Given the transient nature of this change, it is unlikely to be a 
consequence of cell aging. As such, it is likely that even with the improvements 
made, the stage-top incubator (an open-ended system) may not be sufficient for 
extended duration experiments. Future experiments should be adapted to utilise 
a closed system. 
7.2.5 Directional vs non-directional photostimulation. 
Non-directional photostimulation caused significant sarcomeric shortening 
(Figure 4.11). alongside a temporary change in spontaneous cycle length (Figure 
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4.7). These changes were not observed in directionally paced cells indicating 
that the malfunctioning stage-top incubator may have been responsible for these 
changes.  
Directionally paced cells did however show a significant decrease in Up90 (Figure 
6.2). By removing compounding factors such as improper incubator function, and 
variable spontaneous activity it can be concluded that this effect was a direct 
result of the directional pacing protocol. A decreased upstroke time could 
indicate a faster release of calcium from the sarcoplasmic reticulum, a 
functional change that is associated with an increase in maturity166,186,187.  
7.3 Comparison of results with existing literature 
A recent study reported great success in generating adult-like human 
myocardium from iPSC-CMs185. Using field stimulation and flexible pillars to 
induce auxotonic contraction, they were able to simulate intensity training in 
heart tissues engineered from three iPS cell lines. Intensity training (2 weeks at 
a frequency increasing from 2 Hz to 6 Hz by 0.33 Hz per day, followed by a week 
at 2 Hz) proved highly effective when applied to early stage cardiomyocytes 
(immediately following the onset of spontaneous activity). Intensity treated cells 
displayed a positive force frequency relationship similar to adult 
cardiomyocytes, along with a contractile force that was greater than the 
constant frequency (2 Hz for 3 weeks) and control groups but less than the adult 
myocardium. Concomitant with these changes in contraction was an increased 
expression of Ca2+ handling proteins, and an increased responsiveness to 
caffeine, isoproterenol and thapsigargin. Increased sarcomere alignment, a 
sarcomere length similar to adult myocardium, and the presence of t-tubules 
high colocalization of L-type Ca2+ channels to RyR2 were further evidence of the 
increased maturity of these cells. Whilst still below the levels found in adult 
cells, early stage intensity trained cells also displayed an increase in Ik1, lack of 
which is thought to contribute to the spontaneous activity of iPSC-CMs. Other 
maturation techniques are described in Table 7.1. 
The improvement to cell contractility in this project seems modest by 
comparison, however it is likely that it could be enhanced by incorporating 
several elements of the intensity training regime. The cells used in this project 
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were commercially available iPSC-CMs that were pre-matured before shipment. 
As such the plasticity of these cells is likely to be reduced. If the directional 
pacing protocol were to be implemented in early-stage iPSC-CMs it is likely that 
the effectiveness could be increased. Additionally, replicating the mechanical 
environment of the developed heart, either through auxotonic contractions185, 
cyclic stretching52,193 or increased substrate stiffness, could enhance the effects 
of directional pacing. 
The toxicity of prolonged ChR-2 stimulation shown in chapter 5 is consistent with 
recent studies182. Pulsed 473 nm illumination over 3 days produced a strong 
apoptotic effect in melanoma cells expressing the D156A ChR-2 variant but had 
no effect in non-expressing cells. ChR-2(D156A) produced a decrease in 
mitochondrial transmembrane potential and increased caspase-3 production 
consistent with mitochondrial Ca2+ overload induced by Ca2+ ionophore. Lack of 
any significant changes in illuminated, non-expressing cells agrees with the 
findings of this project. 
Table 7.1 Maturation methods and effects 
Intervention 
type 
Intervention Effect 
 
Increased 
substrate 
stiffness 
Increased sarcomere length, increased Ca2+ 
transient amplitude, increased contractile 
force (NRVM)157,194. 
Mechanical Cyclic stretching 
Increased Cx43 expression (hESC-CM)56 and 
localisation (NRVM)53, increased sarcomeric 
organisation (hESC-CM)55, increased 
expression of cardiac specific ion channels 
(hESC-CM)56. 
 
Topographical 
cues 
Reduced circularity, increased sarcomere 
alignment (NRVM)195,196, movement of Cx43 
to periphery(hESC-CM)57 (NRVM)197 
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Table 7.2 Maturation methods and effects (continued) 
Intervention 
type 
Intervention Effect 
Mechanical Dynamic culture 
Increased expression of α-actinin and 
cardiac troponin, increased contractile 
force, increased Ca2+ transient amplitude, 
increased conduction velocity 
(NRVM/hiPSC)198. 
 
72 hrs 5 Hz field 
stimulation 
Increased mitochondrial activity (NRVM)199. 
 
5 days 1 Hz field 
stimulation 
Decreased excitation threshold, increased 
fractional shortening, increased sarcomeric 
organisation (NRVM)48. 
Electrical 
7 days 0.5-2 Hz 
field 
stimulation 
Increased sarcomeric organisation(2 Hz), 
adaptation of spontaneous rate to 
stimulation rate (0.5-2 Hz), increased 
expression of hERG(2 Hz) (hESC-CM)148.  
 
4 weeks 0.5-2 
Hz Field 
stimulation 
Increased contractile force, increased 
sarcomere density (NRVM/hiPSC-CM)51. 
Combined Biowire 
Increased sarcomere organisation, reduced 
threshold potential, increased conduction 
velocity, improved Ca2+ handling, increased 
hERG and IK1 current density (hiPSC)200. 
 
 
Chapter 7 123 
 
Table 7.3 Maturation methods and effects (continued) 
Intervention 
type 
Intervention Effect 
 
Intensity 
training 
Adult sarcomere length, positive force 
frequency relationship, increased Ca2+ 
transient amplitude, increased contractile 
force, increased t-tubule density, increased 
colocalization of Ca2+ handling proteins, 
increased SR capacity and responsiveness, 
increased IK1 current density (hiPSC-CM)185.  
Combined 
Cyclic stretch 
with β-
adrenergic 
stimulation 
Increased contractile force, increased 
expression of β-MHC (NRVM)201. 
 
Cyclic stretch 
and electrical 
stimulation 
Increased contractile force, increased 
contraction and relaxation speed, increased 
SERCA2a expression (NRVM)61 
 
Topographical 
and electrical 
Cell elongation, movement of Cx43 to 
periphery (NRVM)202. 
 
7.4 Future studies 
As shown in chapters 2 and 3, channelrhodopsin based photostimulation is 
incompatible with the optical sensors for voltage and calcium used in house (Di-
4-anepps and Fura-2). Although unavailable for this project there are 
alternative, more compatible techniques, available to allow more detailed study 
of cellular electrophysiology in any future photostimulation studies. The red-
shifted voltage sensitive dye di-4-ANBDQPQ has been shown to allow 
simultaneous photostimulation and voltage recordings147. Alongside this, red-
shifted fluorescent probes(such as Cal-630) and genetically encoded calcium 
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indicators (GECI) have become available allowing for calcium measurements to 
be made alongside photostimulation203. This would allow several of the 
hypotheses proposed during this project to be tested. 
Although MUSCLEMOTION gives many useful characteristics of cardiac 
contractility it does not give any indication of contractile force, a major 
difference between adult cardiomyocytes and iPSC-CMs75,76. Future experiments 
should attempt to determine if there is a corresponding increase in contractile 
force alongside the decreased contraction time. 
In addition to a more detailed investigation of excitation contraction coupling, 
future experiments should look to determine the extent of action potential 
propagation during directional stimulation. This could be achieved with optical 
mapping using a macroscope coupled and an appropriate voltage sensitive 
dye147. Alternatively, microelectrode arrays (MEA) have been used successfully to 
map changes in field potential in a monolayer of iPSC-CMs in response to 
optogenetic stimulation204. 
Finally, the multisite pacing protocol could be altered to include additional sites 
in each well. This would limit the exposure of each site and may allow for a 
single iPSC-CM monolayer to be paced with a 100% duty cycle. 
7.5 Final remarks 
This project has demonstrated that replicating the directional electrical activity 
of the developing heart can induce a modest increase in the functional maturity 
of commercially available iPSC-CMs. 
 
 
 
Appendix 
Python code created to automatically calculate excitability markers from 
strength duration curves. Briefly: signal generator voltage is converted into 
optical power before being plotted against pulse width. A 2nd order best fitting 
exponential is then plotted and the rheobase taken as the minimum y value. The 
chronaxie is taken as the x value associated with a y value twice that of the 
rheobase value. If no exact chronaxie could be determined, the x value 
associated with the median of a list of y values between 1.9-2.1*rheobase was 
taken as chronaxie. Chronaxie and rheobase values can then be saved in a CSV 
file. (Python 2.7.13) 
1. #import pandas as pd   
2. import matplotlib.pyplot as plt   
3. from scipy.optimize import curve_fit   
4. import numpy as np   
5. #import sys   
6.    
7.    
8. pulse = []   
9. Optical_power =[]   
10.    
11.    
12. #returns median of a list of chronaxies   
13. def median(lst):   
14.     sortedLst = sorted(lst)   
15.     lstLen = len(lst)   
16.     index = (lstLen - 1) // 2   
17.    
18.     if (lstLen % 2):   
19.         return sortedLst[index]   
20.     else:   
21.         return (sortedLst[index] + sortedLst[index + 1])/2.0   
22.        
23.        
24. #Convert amplifier voltage to optical power   
25. def Convert(voltage):       
26.     z = ((201.62389*float(voltage)-7.29275)/1000)/0.246   
27.     return z   
28.    
29.    
30. print "How many values?"   
31. No_data = int(raw_input())   
32.    
33. print "Enter pulse widths"   
34. for i in range(0,No_data):   
35.     x = float(raw_input())   
36.     pulse.append(x)   
37.    
38. print "Enter voltages"   
39. for i in range(0,No_data):   
40.     voltage = float(raw_input())   
41.     y = Convert(float(voltage))   
42.     Optical_power.append(y)   
43.    
44. plt.plot (pulse, Optical_power, 'ro')   
45.    
46. x=np.array(pulse)   
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47. y=np.array(Optical_power)   
48.    
49. def func(x, a1, t1, a2, t2, c):   
50.     #return c*(1/x) # simple inverse   
51.     #return b*(1+c/x) #Lapiqcue inverse       
52.     #return b/(1-np.exp(-x/t1)) # Lapiqcue exponential decay   
53.     return a1 * np.exp(-x/t1) + a2*np.exp(-x/t2)+ c #second order exponential   
54.        
55. #popt = an array of Optimal values for the parameters so that    
56. #the sum of the squared residuals of func(x, *popt) - y is minimized   
57.    
58. #pcov = The estimated covariance of popt.   
59.                                            
60. popt, pcov = curve_fit(func, x, y,maxfev=100000)   
61.    
62. #Generate x axis for line of best fit   
63. xx = np.linspace((pulse[0]-0.05),pulse[-1],10000)   
64.    
65. #generate y axis for line of best fit   
66. yy = func(xx,*popt)   
67.    
68. #plot line of best fit   
69. lines = plt.plot(xx, yy, 'r-', label='fit')   
70.    
71. #generate R2 value   
72.    
73. residuals = y- func(x, *popt)   
74. ss_res = np.sum(residuals**2) #residual sum of squares   
75. ss_tot = np.sum((y-np.mean(y))**2) #total sum of squares   
76. r_squared = 1 - (ss_res / ss_tot)   
77.    
78. plt.xlabel('Pulse width (ms)')   
79. plt.ylabel('Optical Power (mW/mm2)')   
80. plt.legend()   
81. plt.show()   
82.    
83.    
84. rheobase = yy[-1:]               
85. chronaxies = []   
86.    
87. for x in xx:   
88.     z = np.where(xx==x)   
89.     if yy[z]==(rheobase*2):   
90.         chronaxie =x   
91.         break   
92.     #if no exact match, make list of values around chronaxie   
93.     elif yy[z]>=(rheobase*1.9) and yy[z]<=(rheobase*2.1):   
94.         chronaxies.append(x)   
95.        #print chronaxie   
96.     else:   
97.         chronaxie = 0   
98.    
99. #identify chronaxie as the median value of the list of chronaxies   
100. if chronaxie == 0:   
101.     chronaxie = median(chronaxies)       
102.            
103.        
104. rheobase = str(rheobase)[2:-1]   
105.        
106. print "Rheobase: "+str(rheobase)[0:-4]+" mW/mm2"   
107. print "Chronaxie: "+str(chronaxie)[0:-6]+"ms"   
108. print "R_squared: "+str(r_squared)[0:5]   
109.    
110. root='C:/Users/User/Documents/Thesis/Strength duration curves/'   
111.    
112. print "Do you want to save these results?"   
113. answer = raw_input()   
114.    
115. if answer == "yes" or answer == "y":   
116.     file = open(root+"electric 2nd order.csv",'a')   
Appendix 127 
 
117.     file.write("Rheobase," + str(rheobase)[0:4] +  
118.                ",Chronaxie," + str(chronaxie)[0:-6]+",\n")   
119.     file.close()   
120.    
121. #store variables for next run to check for errors   
122. mem_chronaxie=chronaxie   
123. mem_rheobase=rheobase   
124. mem_chronaxies = chronaxies   
125. #reset variables   
126. chronaxies = []   
127. chronaxie = 0   
128. rheobase = 0   
128 
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